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ABSTRACT 
 
Impact of Dietary Arginine on Immunity in Broiler Chicks 
Jennifer Lynn D’Amato 
 
Arginine (ARG) is an immunologic modulator due in part to its role as a substrate 
for leukocytes.  Therefore, the objective of these studies was to evaluate the impact of 
dietary ARG on ARG utilization in peripheral blood mononuclear cells (PBMC) and 
thymocytes in broiler chicks as they provide a model that is not confounded by de novo 
ARG synthesis.  Several experiments were performed to measure: 1) ARG transporters as 
markers of ARG utilization by leukocytes; 2) thymocyte proliferation; 3) PBMC 
phenotype, and 4) ARG’s impact on the acute phase response (APR).  In experiment 1, 
chicks were fed diets containing 1.20% or 1.35% dietary ARG.  On d7, PBMC CAT-1 
mRNA abundance was 2-fold higher in chicks fed 1.35% ARG than in those fed 1.20% 
ARG (P<0.05).  Between d3 and d14, 1.20% ARG increased thymocyte y+LAT-2 mRNA 
abundance 2.5-fold (P<0.05) while 1.35% ARG did not.  In experiments 2 and 3, chicks 
were fed diets containing 1.1%, 1.3%, and 1.5% dietary ARG.  On d10, 1.5% ARG 
reduced thymocyte proliferation compared to 1.1% and 1.3% ARG (P<0.05).  The 
percentage of peripheral blood B cells tended (P=0.06) to have an age by ARG 
interaction.  On d14, but not on d10 or 17, the percentage of monocytes from chicks fed 
1.5% was higher than from those fed 1.1% and 1.3% ARG (P<0.05).  In experiment 3, 
chicks from four replicate pens per treatment were not injected (control) or injected 
subcutaneously with Salmonella typhimurium lipopolysaccharide (LPS; 1 mg/kg BW) to 
initiate the APR.  At 2 h post LPS injection, there tended (P=0.08) to be a LPS by ARG 
interaction for TGF-β4 mRNA abundance.  Therefore, these studies indicate that the 
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optimal level of dietary ARG supplementation for utilization by ARG transporters in 
leukocytes is higher than what is sufficient for growth and is both age and leukocyte 
dependent.  Additionally, these studies indicate that dietary ARG levels above the NRC 
requirement may be beneficial for the abundance of PBMC sub-populations.  These 
studies also indicate that the APR may be manipulated by dietary ARG. 
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CHAPTER 1 
Introduction 
1.1. Arginine is Essential for the Growth of Chickens 
 
1.1.1. Arginine Metabolism 
Arginine (ARG) is a cationic amino acid (CAA) as it has both a positively 
charged R-group and guanidino group.  It is polar, basic, and required for growth.  It is 
both an essential and conditionally essential amino acid due to species differences in 
ARG metabolism.  In uricotelic species, ARG is essential due to an incomplete urea cycle 
as ARG is not necessary to excrete nitrogenous waste (1).  In chicks, dietary ARG must 
be provided due to a lack of mitochondrial carbamylphosphate synthetase I (CPS I) as 
well as low renal argininosuccinate synthetase (AS), argininosuccinate lyase (AL), and 
ornithine transcarbamylase (OTC) activity (1).  The ARG requirement for chicks is 
among the highest documented in model species; however, ARG requirements can be 
spared by dietary citrulline supplementation (1).  In ureotelic species with a functioning 
urea cycle, ARG is conditionally essential (young, growing animals) or nonessential 
(healthy adults) (1-2).   
ARG metabolism begins with the ingestion and digestion of proteins in the 
gastrointestinal tract.  In the small intestine, proteins are cleaved into amino acids and 
peptides by enzymes such as trypsin, carboxypeptidases, aminopeptidases, and 
aminodipeptidases.  The component amino acids and peptides, particularly dipeptides, are 
absorbed from the intestinal lumen and transferred to the liver via the portal system (3).  
This allows the liver an opportunity to take up nutrients from circulation before other 
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tissues (3).  The release of amino acids and peptides into the portal vein depends on 
dietary factors including the amount and biological value of the protein consumed, and 
other macronutrients consumed, and non-dietary factors including gut protein synthesis 
and physiologic state (4).  In enterocytes, amino acids are transported by many transport 
systems including systems: L, B0, asc, y+L, y+, and b0,+ (5-6), and peptides are transported 
by PepT-1 (7).   Of the amino acid systems, ARG is transported by systems: y+, y+L, and 
b0,+ (5-10).  In chickens, amino acids are mostly absorbed in the duodenum, but are also 
absorbed in the jejunum, and ileum (11).  After absorption amino acids can be 
transaminated or deaminated, utilized for the synthesis of proteins, enzymes, hormones, 
and other metabolites, and their carbon skeletons can be oxidized for energy or 
gluconeogenesis (3).  ARG is used for protein synthesis and is a precursor of a variety of 
compounds including ornithine, polyamines, proline, glutamate, urea, creatine, nitric 
oxide (NO), citrulline, and agmatine in reactions initiated by arginases, nitric oxide 
synthases (NOS), ARG:glycine (GLY) amidinotransferase, and ARG decarboxylase (8-9, 
12-13).  ARG is initially metabolized to ornithine, urea, NO, citrulline, and agmatine 
while additional enzymatic steps occur in the synthesis of polyamines, proline, glutamate, 
and creatine (12).  For instance, ARG’s guanidino group is transferred to GLY to produce 
guanidinoacetate which is later converted to creatine (12). 
ARG can be catabolized by arginase into ornithine and urea (12-13).  Ornithine is 
a precursor for polyamines which are ubiquitous low molecular weight aliphatic cations 
(14) and include putrescine, spermidine, and spermine (13).  In mammals there are two 
types of arginase, arginase I and arginase II, encoded by different genes (12-13, 15).  
They differ in tissue and subcellular distribution (12-13, 15).  Arginase I is in the cytosol 
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and is highly expressed in the liver as part of the urea cycle, whereas arginase II is in the 
mitochondrial matrix and is expressed in the kidney, brain, small intestine, muscle cell, 
mammary gland, and macrophage (8-9, 12, 16).  In chicks, arginase activity is 
approximately 30 times higher in the kidney than in liver (1).  ARG is also a substrate for 
nitric oxide synthases (NOS) which produce NO and citrulline (8, 12-13).  There are 
three NOS enzymes, inducible NOS (iNOS), endothelial NOS (eNOS), neuronal NOS 
(nNOS) (8, 12-13).  eNOS and nNOS are constitutively expressed and Ca2+-dependent 
while iNOS is induced in response to bacterial endotoxin and proinflammatory cytokines 
and is Ca2+-independent (9, 12).  NO production is rate-limited by the availability of 
intracellular ARG (8).  Arginase and NOS compete for ARG; therefore, in many cell 
types relative enzymatic activities (Km values for arginase and NOS are 2-20 mM and 2-
20 µM, respectively; the Vmax of arginase is much higher than that of NOS) and the 
induction of NOS determine polyamine and NO production (2, 9, 15). 
Endogenous ARG is predominately synthesized from citrulline through the 
intestinal-renal axis in ureotelic animals (2, 8-9, 15).  Enterocytes produce citrulline from 
glutamine metabolism and release it into the blood where it is transported to proximal 
tubular cells in the kidney, converted to ARG, and released into the circulation (8-9, 12, 
15).  As citrulline is also a by-product of NO production, ARG can be synthesized 
through the citrulline-NO cycle if AS and AL are present in the cell; however, this 
pathway is inefficient compared to the intestinal-renal axis (8, 15).  ARG is also 
synthesized in the liver within the hepatic urea cycle; however, there is little or no net 
synthesis due to the high hepatic arginase activity and the tight channeling of metabolites 
from enzyme to enzyme in the urea cycle (8-9). 
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ARG metabolism is regulated by many factors including diet, hormones, 
cytokines, bacterial endotoxins, and ARG availability (9, 15).  For example, dietary 
changes in protein intake and subsequent alterations in amino acid nitrogen flux result in 
changes in the activities of urea cycle enzymes (15).  In hepatocytes and enterocytes, 
glucocorticoids regulate ARG metabolism by upregulating arginase while 
downregulating NOS (9).  Additionally, arginase and NOS are differentially expressed 
due to induction by different classes of cytokines (9, 13).  In addition, ARG availability 
has been shown to impact gene expression of urea cycle enzymes and ARG transporters 
though many of the mechanisms by which this occurs have not been elucidated (2).  
 
 1.1.2. Arginine Utilization for the Growth of Chickens 
 Amino acid utilization for growth has been studied at the tissue level.  Dean and 
Scott (17) developed an amino acid reference diet for chicks in a historic study that 
allows for the use of essential amino acid ratios to formulate and evaluate diets.  From 
this study, the ideal protein concept was established as it aims to provide a precise ratio 
of essential amino acids to lysine (LYS) that meet the needs for protein accretion and 
maintenance while minimizing nitrogen excretion (18).  Studies that followed this work 
aimed at determining these ratios to maximize growth.  In the case of LYS and ARG, 
both are limiting cationic amino acids required for growth; however, it was determined 
that they can have an antagonistic relationship such that a growth depression occurs if 
LYS is provided in excess of ARG due to an increase in ARG catabolism through renal 
arginase (1, 19).  In order to correct this antagonism, the ARG requirement is increased 
(19).  In chicks, this antagonism has been reported with dietary LYS levels between 2% 
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to 3.5% or when the LYS to ARG ratio was 2.2-2.6:1 (1).  In studies focusing on ARG 
utilization in chickens, dietary ARG supplementation above the National Research 
Council (NRC) requirement (20) increases feed intake, body weight, pectoralis weight, 
feed efficiency, carcass yield, and plasma ARG concentrations (21-24). 
 
1.2. Arginine is Essential for Immunity of Chickens 
 
 1.2.1. Overview of the Immune System 
 The immune system consists of the innate and adaptive branches which are 
coordinated by cytokines and other cell signaling molecules to effectively respond to 
pathogens and other antigens.  The innate system is constitutive, recognizes pathogen 
associated molecular patterns, and acts in the initial stages of infection (25-26).  It has 
low receptor specificity and diversity, and includes natural killer cells, dendritic cells, 
monocytes/macrophages, and granulocytes which include neutrophils (heterophils in 
aves), eosinophils, and basophils (25, 27-28) (Table 1).  Natural killer cells are involved 
in viral immunity (29) while dendritic cells and macrophages are phagocytic antigen-
presenting cells (28).  Granulocytes are also phagocytic, but unlike dendritic cells and 
macrophages, they have many granules containing lytic enzymes and antimicrobial 
molecules (28).  Of the granulocytes, neutrophils respond early on in immune responses 
and are important in response to bacterial infections whereas eosinophils are involved in 
parasitc infections, and basophils mediate allergic responses (28).  Effector molecules 
produced by innate immune cells include reactive nitrogen species (RNS), reactive 
oxygen species (ROS), defensins, cytokines, lysozyme and other hydrolytic enzymes (27-
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28).  Innate immunity is nutritionally expensive as the costs in mounting an immune 
response do not diminish with repeat exposure to a particular pathogen (25). 
The adaptive immune system consists of cell-mediated and humoral immunity 
and is characterized by the generation of antigen-specific effector and memory T helper 
(TH) cells, cytotoxic T lymphocytes and B cells.  Both TH cells and B cells are important 
in immune responses to extracellular pathogens while cytotoxic T lymphocytes are 
important in immune responses to intracellular pathogens (28).  Lymphocyte effector 
molecules include cytokines and immunoglobulins.  Adaptive immunity is less 
nutritionally expensive than innate immunity once a repertoire of antigen-specific B and 
T lymphocytes have been developed (25).   
Additionally, the immune system is organized into primary and secondary 
lymphoid tissues.  Lymphopoiesis occurs in primary lymphoid tissues which include the 
bone marrow (mammals) or bursa (aves) and thymus where B and T lymphocytes are 
produced, respectively, whereas lymphocytes encounter antigens in secondary lymphoid 
tissues which include the spleen, lymph nodes, and gut, bronchial, mucosal, and 
cutaneous associated lymphoid tissues (27). 
 
1.2.2. Avian Leukocytes  
Avian leukocytes include monocytes/macrophages, granulocytes which include 
heterophils, eosinophils, and basophils, and lymphocytes.  Additionally, cell types similar 
to mammalian natural killer cells and dendritic cells have been identified.  The natural 
killer cell candidate has been found in the thymus, bursa, spleen, and intestinal epithelium 
of chickens (28).  Similar to their mammalian counterparts, avian 
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monocytes/macrophages originate from bone marrow, are phagocytic, and produce NO 
(30-31).  Avian heterophils, like mammalian neutrophils, mediate acute inflammation, are 
important in bacterial infection, produce ROS, and are phagocytic (32-33).  Avian 
lymphocytes include TH cells, cytotoxic T lymphocytes, and B cells and are capable of 
chemotaxis as are mammalian lymphocytes (34).  Both mammalian and avian TH cells 
secrete cytokines and both B cells produce immunoglobulins; however, chicken B cells 
produce IgY, IgM, and IgA while mammalian B cells produce IgG, IgE, IgM, IgA, and 
IgD (28). 
 Nutrients and infection impact the numbers, locations, and functions of avian 
leukocytes.  Avian macrophages and lymphocytes are impacted by several nutrients 
including vitamins, minerals, amino acids, and amino acid derivatives that can be 
supplemented in the diet.  Examples of these include zinc, vanadium, vitamin A, vitamin 
D, vitamin E, isoleucine, valine, betaine, and β-hydroxy-β-methylbutyrate (31, 35).  For 
instance, when zinc-methionine is supplemented in the diet, macrophages isolated from 
turkeys have enhanced in vitro phagocytosis of Salmonella enteritidis and increased 
Escherichia coli clearance from blood (31).  Also, in chicks supplemented with dietary 
betaine, monocytes and macrophages have improved chemotactic abilities and NO 
production (35).  In avian lymphocytes, the numbers of peripheral blood lymphocytes are 
decreased with feed restriction, malnutrition, and protein restriction (32, 35-36).  In 
addition, protein restriction decreases splenocyte proliferation in response to the mitogen 
phytohemagglutinin (PHA) (35).  Also, vitamin E dietary supplementation increases the 
percentages of thymic and splenic TH cells (35) while dietary valine supplementation 
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above requirements for growth increases antibody production to Newcastle’s disease 
virus (35). 
Avian macrophages and lymphocytes are also impacted by different types of 
infections including bacterial and parastic infections (31), and by antigenic molecules that 
mimic infections such as lipopolysaccharide (LPS) from gram-negative bacterial cell 
walls.  For instance, there are few resident macrophages in the avian respiratory tract, but 
if live E. coli or Salmonella typhimurium are introduced, macrophage phagocytic ability 
is enhanced and peripheral blood monocytes migrate to the site of infection (31).  Also, 
LPS administration decreases the concentration of lymphocytes in peripheral blood 
shortly after exposure (32) and when exposed to LPS in vitro avian lymphocytes exhibit 
increased chemotaxis (34) and proliferation (37). 
 Avian granulocytes are impacted by nutrition and infection as well.  Under 
varying degrees of feed restriction, the percentage of peripheral blood heterophils and 
basophils increase while the percentage of eosinophils decrease (36).  In addition, dietary 
ascorbic acid supplementation, tended to decrease random migration and increase 
Staphylococcus aureus clearance by heterophils in vitro (38).  Shortly after intravenous 
LPS administration, the concentration of heterophils in peripheral blood increases (32).  
Additionally, during infection with S. enteritidis, heterophils are recruited from 
circulation to sites of inflammation in the intestinal mucosa, and in chickens with induced 
heteropenia, S. enteritidis pathogenicity is increased (39). 
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1.2.3. Overview of the Interaction between Nutrition, Metabolism, and 
Immunity 
Nutrition, metabolism, and the immune system are closely intertwined as 
metabolism determines the fate of nutrients for physiological processes while the immune 
system is reliant on these nutrients to function.  For example, when lymphocytes are 
activated there is an increase in their metabolic rate and they rely on having adequate 
nutrients as they rapidly proliferate and produce antibodies, cytokines, and other cell 
signaling molecules (27, 40).  Additionally, regulation of metabolism overlaps with 
regulation of the immune system as hormones, cytokines, and other factors act on both 
non-immune and immune cells and tissues.  For instance, hormones such as insulin that 
regulate energy metabolism also act on lymphocytes which preferentially utilize glucose 
and glutamine for energy (40-41).  In metabolism, insulin stimulates glucose uptake and 
utilization by tissues, and in activated T cells insulin promotes T cell responsiveness (27, 
41).  
 Nutrition can be utilized to manipulate the immune system.  Mechanisms by 
which nutrition modulates the immune system include altering signal transduction in 
leukocytes (polyunsaturated fatty acids, vitamins A, D, E), providing substrate for 
immune cells (amino acids, trace minerals) or pathogens (iron, biotin), protecting against 
immunopathology (antioxidants), and influencing gut microbial populations (fiber) and 
the hormonal environment (protein:energy ratio) (25-26).   
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1.2.4. Arginine Utilization for Immunity 
ARG has a role in a mechanism of immunomodulation in part as a substrate for 
the immune system (22).  ARG supplementation improves wound healing associated with 
surgery or trauma and improves survival in rodent and human tumor models (27, 42-44) 
which has resulted in many studies attempting to understand how ARG supplementation 
impacts the immune system.  It has been determined that ARG utilization by immune 
cells has important implications regarding their function.  For example, in B cells, an 
ARG deficiency impacts early B cell maturation in the bone marrow of transgenic mice at 
the pro- to pre-B cell transition and decreases the proportion of B cells in the lymph 
nodes, small intestine, and spleen, but does not impact mature B cell proliferation in 
activated B cells (45).   
In T cells, ARG regulates development and function (Figure 1).  The T cell 
receptor (TCR) complex includes the CD3ζ chain which is the primary signal 
transduction element of the TCR (46).  In Jurkat CD4+ T cells, the absence of ARG 
decreases CD3ζ chain expression in vitro; however this was reversed by replenishing 
ARG (46).  Furthermore, CD3ζ chain mRNA abundance and half-life were decreased 
(46).  In activated human peripheral blood T cells, the absence of ARG interferes with 
normal TCR cycling and CD3ζ chain re-expression in vitro; however, unlike in Jurkat T 
cells, this was not accompanied by a decrease in CD3ζ chain mRNA abundance (47).  In 
addition, the absence of ARG results in a decrease in T cell proliferation and cytokine 
production in vitro (47) and has been associated with a decrease in T cell proliferation 
and cytokine production in vivo when extracellular ARG is diminished in response to 
surgery, trauma, or sepsis (46-48).  Furthermore, in human peripheral blood T cells, the 
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absence of ARG blocks in vitro proliferation by arresting the cells in the G0-G1 phase of 
the cell cycle (48). 
In macrophages (activated monocytes), ARG is a substrate for iNOS or arginase 
and generates NO, an important cytotoxic molecule, and citrulline or ornithine, a 
precursor for polyamines, and urea depending on cytokine signals (Figure 2).  For 
example, in casein-elicited rat macrophages, there is an increase in iNOS protein as well 
as an increase in nitrite and citrulline production from radiolabeled ARG in vitro (49).  
Additionally, in the avian macrophage cell line, HD11, ARG and lipopolysaccharide 
(LPS) influence production of nitrite in a dose-dependent manner (30).  ARG utilization 
in macrophages may also have a role in modulating T cells.  In murine macrophages 
stimulated with TH2 subset cytokines (addressed below) in vitro, extracellular ARG is 
depleted when arginase I, but not arginase II or iNOS, is upregulated (50).  Furthermore, 
when cocultured with Jurkat CD4+ T cells this depletion results in a decrease in CD3ζ 
chain expression and inhibits proliferation (50). 
 
1.2.5. Arginine Utilization for Immunity of Broiler Chickens 
ARG utilization for immunity has been studied in broiler chicks as they provide a 
model that is not confounded by de novo ARG synthesis.  It has been determined that 
dietary ARG levels 100% and 120% of the NRC requirement do not impact cutaneous 
basophil hypersensitivity which was used to assess cell-mediated immunity, sheep red 
blood cell antibody titer which was used to assess humoral immunity, relative lymphoid 
organ weights, or blood leukocyte counts (22).  However, in another study dietary ARG 
supplementation to deficient diets improved cutaneous basophil hypersensitivity, 
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antibody titer to Newcastle disease virus, and relative thymic and spleen weights (51).  In 
broilers vaccinated with a live infectious bursal disease virus, dietary ARG above the 
NRC requirement increases the proportion of T cells and B cells in peripheral blood (52).  
Also as dietary ARG increases, microbial infections detected during processing diminish 
(24).  Therefore, even though dietary ARG supplementation in broilers has provided 
inconsistent results it is apparent that the immune system requirement for ARG warrants 
further study. 
 
1.3. Arginine Transporters 
 Tissues and cells such as immune cells require nutrients to maintain physiological 
processes and have different nutrient priorities.  For instance, within the immune system, 
nutrient priority is highest for macrophages and lowest for T cells while B cells fall 
somewhere between (26).  Tissues acquire these nutrients through nutrient transporters 
which mediate transport across the plasma membrane (26).  In the case of ARG, there are 
three gene families encoding four transport systems that are responsible for its transport 
(53-55).  The system y+ cationic amino acid transporter (CAT) family which imports 
CAA independently of Na+ resulting in an influx of CAA (6, 12, 53, 55-58).  The systems 
y+L and b0,+ glycoprotein-associated amino acid transporter (gpaAT) family (also referred 
to as the light chains of the heterodimeric amino acid transporters) in which y+LAT-1 and 
-2 exchange Na+ and large NAA for CAA resulting in efflux of CAA and b0,+AT 
exchange large NAA and CAA independently of Na+ resulting in an influx of CAA (5-6, 
10, 12, 53, 55, 58).  The system B0,+ of the Na+/Cl- dependent transporter family in which 
B0,+AT imports NAA and CAA in a Na+/Cl- dependent manner (12, 53, 55, 58) (Table 2). 
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 1.3.1. System y+  
 System y+ includes glycosylated transmembrane transporters CAT1-4 (6, 58).  
CAT-1 and -3 are more closely related than CAT-4 (6, 58) while CAT-2A and CAT-2B 
are formed by the same gene by alternative splicing (6, 8, 56, 58).   
In mammals, CAT-1 is ubiquitously expressed at varying levels with the 
exception of the liver (6, 8, 56, 58) and is the predominate system y+ transporter in most 
cell types.  CAT-1 expression is modulated by cell proliferation, growth factors, 
cytokines, and hormones and its expression is elevated during nutrient limitation (6).  
CAT-2A is present in the liver and has a low affinity while CAT-2B has a high affinity 
(6, 8, 12, 56).  CAT-2B expression increases after cytokine or LPS stimulation and is 
often co-induced with iNOS in several cell types (6, 12, 58).  The associated induction of 
CAT-2B and iNOS probably acts to increase ARG transport in support of elevated NO 
production as Nicholson et al. (56) indicated that CAT-2 is necessary for sustained NO 
production in macrophages.  CAT-3 is found in the brain (8, 12), and in humans it is 
strongly expressed in the thymus (6, 58).  CAT-4 is found in the brain, testis, and 
placenta, but its function is largely unknown (6).  In humans an activation of transport 
through y+ has been reported in T cells stimulated with PHA in vitro (59).   System y+ is a 
high affinity transport system (except for CAT-2A with a Km of 2-5 mM) with Km values 
ranging from 0.025 to 0.4 mM (6, 53-54, 57-58).   
In broiler chicks, CAT isoforms are also expressed though their tissue distribution 
in some cases differs from that of mammals.  For instance, unlike in mammals, CAT-1 is 
expressed in liver.  CAT-1 is also expressed in gastrocnemius, pectoralis, and bursa but is 
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not expressed in heart, spleen, and thymus (53).  Similar to CAT-1, CAT-2 is expressed 
in gastrocnemius, liver, pectoralis, and bursa, but unlike CAT-1, is also expressed in 
heart, spleen, and thymus (53).  CAT-3 is expressed in pectoralis, bursa, heart, spleen, 
and thymus, but not in gastrocnemius and liver.  CAT isoform expression is dependent on 
chick age.  For instance, CAT-2 and -3 are not detectable in the thymus on d1 posthatch 
but are expressed on d7 posthatch (53).  In lymphocytes CAT isoform expression differs 
some from bursa and thymus as CAT-1 and CAT-3 are expressed in bursacytes and 
thymocytes, but CAT-2 is not (55).  An additional difference between mammals and 
broiler chicks in CAT isoform expression is in the alternate splicing of CAT-2.  Similar 
to mammals, CAT-2A and CAT-2B have been identified in chickens; however, an 
additional CAT-2 isoform, CAT-2C has also been identified (60). 
  
1.3.2. System y+L and System b0,+ 
  Systems y+L and b0,+ includes unglycosylated transmembrane transporters 
y+LAT1/2 and b0,+AT (6, 58).  In these systems from the gpaAT family, cell-surface 
expression is dependent upon covalent association with a type II surface glycoprotein 
(4F2hc or rBAT) (5-6, 10).  y+LAT1/2 associate with 4F2hc while b0,+AT associates with 
rBAT (5, 10).  These transporters are obligatory exchangers (5-6, 10, 58).  y+LAT-1 and 
b0,+AT are primarily expressed in epithelia with the highest mRNA abundance in the 
small intestine and kidney indicating that they are important in absorption and 
reabsorption of amino acids whereas y+LAT-2 is rather ubiquitously expressed (5-6, 10, 
58).  System y+L and system b0,+ are high affinity transport systems with apparent Km 
values between 5-10 µM and 20-80 µM, respectively (5-6).  In humans, only minimal 
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transport of CAA through system y+L has been reported in lymphocytes (59).  In 
lymphocytes 4F2hc is barely detected in resting cells, but is strongly induced in 
proliferating cells presumably to provide amino acids necessary for synthesis of cell 
proteins in preparation of cell division (5-6, 10). 
  
1.3.3. System B0,+ 
 System B0,+ includes glycosylated transmembrane transporter ATB0,+ (58).  
ATB0,+ is a high affinity transporter with apparent Km values between 0.10 and 0.15 mM 
(58).  It is most abundant in the lung and salivary gland, but is also found in the 
mammary gland, pituitary gland, and stomach (53, 55, 58).  
 
1.4. The Acute Phase Response and TH Subset Cytokines 
 
 1.4.1. The Acute Phase Response 
 There are alterations in nutrient metabolism and nutrient partitioning when the 
immune system is activated (26).  A specific instance of this alteration is demonstrated 
with the acute phase response (APR) which can be induced with LPS (61-62), and refers 
to the metabolic changes that occur after tissue injury or immune challenge resulting in 
an inhibition of growth, the production of hepatic acute phase proteins, and the 
recruitment and proliferation of immune cells (25, 61, 63).  For instance, a metabolic 
change observed in chickens is an increase in the fractional synthesis rate of hemopexin, 
an acute phase protein, in LPS-injected chicks (63).  Other markers associated with the 
acute phase response include: fever, anorexia, increased hormone and cytokine synthesis, 
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and leukocytosis (29, 54, 61).  In broiler chicks, examples of these markers include 
elevated cloacal temperature at 3 h post-LPS injection and elevated plasma levels of IL-6 
at 12 h post-LPS injection (64).  During the APR, the alteration in protein metabolism is 
quite impressive as the immune system tends to use a large amount of available amino 
acids for host defense resulting in a decrease in muscle protein synthesis and an increase 
in muscle protein degradation (63, 65-68).  For example, E. coli injection in chickens 
increased protein catabolism in the muscle, spleen, and thymus 43, 30, and 34%, 
respectively, but did not impact protein catabolism in the liver or bursa (69), whereas the 
fractional synthesis rate of protein increased in the liver and decreased in muscle (65).  
Additionally, there may be excessive muscle protein catabolism in order to supply the 
necessary amount of limiting amino acid needed for synthesis of acute phase proteins 
(67-68).  For instance, some human acute phase proteins have high concentrations of 
phenylalanine, tryptophan, and tyrosine which results in the degradation of muscle 
protein in excess of the quantity of acute phase proteins synthesized (67). 
 
 1.4.2. Arginine and the Acute Phase Response 
The alteration in metabolism during the APR has implications for ARG utilization 
by immune cells and tissues.  During the APR, ARG is metabolized to produce NO in 
macrophages and to support increases in immune cell proliferation (21-22, 70).  For 
instance, in broiler chicks fed ARG above the NRC requirement, there is an increase in 
plasma nitrite concentration and splenocyte proliferation in response to LPS injection 
(71).  Similarly, in other species, such as rats, mice and pigs, dietary ARG 
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supplementation enhances immune responses to pathogens or bacterial endotoxins (9, 27) 
whereas ARG deficiency impairs nitrite production in response to LPS injection (72). 
 
 1.4.3. TH Subset Cytokines 
 
 Cytokines are hormone-like peptides that coordinate immune responses (29, 73).  
They are secreted by immune cells, act locally, are antigen nonspecific, and are both 
pleiotropic and redundant (29).   Cytokines can be divided into four main subsets: 
proinflammatory cytokines, TH1 subset cytokines, TH2 subset cytokines, and TH3 subset or 
anti-inflammatory cytokines.  Proinflammatory cytokines initiate an innate immune 
response and generate localized inflammation and include interleukin (IL)-1β and IL-6 
(73).  IL-1β is produced by macrophages, mediates the acute phase response, increases in 
vitro CAT expression and activity in mammals, and stimulates neutrophil production (29, 
54, 62, 74).  IL-6 is produced by T cells and macrophages, stimulates acute phase protein 
production, elevates serum corticosterone levels, and induces B cell maturation (74-75).  
Both IL-1β and IL-6 induce antibody production and fever (29, 62).  TH1 subset cytokines 
promote cell-mediated immunity and include IL-12, IL-18, and interferon (IFN)-γ (76).  
IL-18 is produced by activated macrophages and induces IFN-γ production by T cells and 
natural killer cells (74).  IFN-γ induces secretion of NO in macrophages, and increases 
CAT expression and activity in vitro (54, 62, 74).  TH2 subset cytokines promote humoral 
immunity (76) and include IL-3, IL-4, IL-5, IL-9, and IL-13.  IL-4 is produced by T cells, 
stimulates growth and differentiation of B cells and suppresses TH1 cells (28, 74).  IL-13 
is produced by T cells and causes B cell growth while inhibiting inflammatory cytokine 
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production by macrophages (74).  TH3 subset or anti-inflammatory cytokines include IL-
10 and transforming growth factor-β (TGF-β).  IL-10 is synthesized by T cells and 
macrophages and inhibits IFN-γ synthesis in activated lymphocytes (74, 77).  TGF-β is 
immunostimulatory or immunosuppressive depending on the stimulus and target cell type 
such that it is immunosuppressive on activated lymphocytes, monocytes, and 
macrophages (62).  
 
 1.4.4. Avian TH Subset Cytokines 
 Avian orthologs to mammalian cytokines have been identified (75, 78-82).  
Additionally, avian cytokines are also divided into proinflammatory, TH1, TH2, and anti-
inflammatory subsets (78, 83).  Like mammalian proinflammatory cytokines, avian 
proinflammatory cytokines include IL-1β and IL-6, elevate serum corticosterone levels, 
and are produced by macrophages (75, 80).  Avian TH1 subset cytokines include IL-12, 
IL-18, and IFN-γ similar to their mammalian counterparts, and like mammals, IL-12 
requires both subunits for functionality, induces IFN-γ production by splenocytes, and 
induces spleen cell proliferation (82), while IFN-γ induces nitrite production by 
macrophages (81).  Avian TH2 subset cytokines include IL-3, IL-4, IL-5, IL-9, and IL-13 
(78).  This is similar to mammals except in chickens IL-5 is a pseudogene (78).  IL-3, IL-
4, and IL-13 are expressed in a variety of stimulated leukocytes and lymphoid and non-
lymphoid tissues such as splenocytes, bursacytes, thymus, bursa, lung, and brain (78).  
IL-4 and IL-13 also stimulate B cell proliferation similar to these mammalian cytokines 
(78).  Like mammalian anti-inflammatory cytokines, avian anti-inflammatory cytokines 
include IL-10 and TGF-β; however, in mammals TGF-β genes do not include TGF-β4 as 
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they do in chickens (84).  It has been suggested that chicken TGF-β4 is actually chicken 
TGF-β1 as its established function is equivalent to mammalian TGF-β1 (84).  Also, TGF-
β4 is the most commonly expressed isoform in chickens (84). 
 Avian TH subset cytokine profiles change in response to nutrition.  For instance, 
serum concentrations of IL-1 increase in chickens injected with a series of immunogens 
including E.coli LPS, S. typhimurium LPS, and S. aureus when fed a methionine-
sufficient diet compared to those fed a methionine-deficient diet (85).  Likewise, plasma 
IL-1 levels increase in LPS-injected chicks fed a diet high in cysteine compared to diets 
low or medium in cysteine or deficient in sulfur amino acids (71).  In addition, cytokine 
expression does not respond solely to dietary amino acids; for example, an increase in 
splenic IL-1β expression in LPS-injected chicks was impacted by dietary vitamin E (62), 
whereas dietary supplementation of n – 3 polyunsaturated fatty acids increased IFN-γ 
mRNA abundance in LPS-injected chickens (86).   
Avian TH subset cytokine profiles change in response to infection as well.  For 
instance, of the proinflammatory cytokines, IL-1β expression is induced in response to 
LPS in macrophages (75) and splenocytes (61), and IL-6 expression in PBMC is 
decreased after oral exposure to S. enteritis (84), and increased in plasma in LPS-injected 
chickens (64).  Of the TH1 cytokines, IL-12 expression is increased in splenocytes, an 
avian macrophage cell line, and an avian B lymphocyte cell line when stimulated with 
LPS in vitro (82), and IL-18 expression is increased in the spleen after S. enteritis 
exposure (77).  Also, IFN-γ expression is increased in the spleen and ileum after exposure 
to Newcastle disease virus (83) and is increased in the spleen and splenocytes after 
exposure to S. enteritis and S. typhimurium LPS, respectively (61, 77).  Of the TH2 
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cytokines, ileal IL-13 expression is increased with Ascaridia galli infection (83).  Of the 
anti-inflammatory cytokines, TGF-β2 splenocyte expression is increased when incubated 
with LPS in vitro (61), whereas TGF-β4 PBMC expression is decreased after in vitro S. 
enteritis exposure (84).    
 
Many studies have addressed ARG’s impact on the immune system; however, few 
have utilized broiler chicks as a model not complicated by de novo ARG synthesis to 
examine ARG’s impact on the cellular level by considering markers of ARG utilization.  
Additionally, in broiler chicks, dietary ARG is provided to maximize growth; however, it 
is unknown if the NRC requirement for growth is optimal for immunity.  Therefore, in 
the present study the following was determined: ARG transporter mRNA abundance as a 
marker of ARG utilization by peripheral blood mononuclear cells (PBMC); thymocyte 
proliferation as an indication of T cell function in response to dietary ARG; PBMC 
phenotype, and ARG’s impact on the severity of the APR by considering PBMC 
phenotype and splenic cytokine profiles.   
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Table 1. Cells of the innate immune system 1 
Cell Type Express PRR Phagocytose Produce 
RNS/ROS 
Present 
Antigen 
Natural killer cells No No No No 
Dendritic cells Yes Yes Yes Yes 
Monocytes/macrophages Yes Yes Yes Yes 
Granulocytes Yes Yes Yes No 
1
 Abbreviations: PRR, pattern recognition receptors; RNS, reactive nitrogen species; 
ROS, reactive oxygen species.
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Table 2. ARG transporter systems 1 
Transport 
System 
Gene Gene 
Products 
Substrates Function Sodium 
Dependence 
Site Tissue Distribution 
y+ SLC7A1 
SLC7A2-A 
SLC7A2-B 
SLC7A3 
SLC7A4 
CAT-1 
CAT-2A 
CAT-2B 
CAT-3 
CAT-4 
LYS, ARG Imports CAA, NAA, 
and Na+; influx of 
CAA 
Independent 
for CAA; 
dependent for 
NAA 
BLM Widespread, liver, 
skeletal muscle, 
macrophages 
y+L SLC7A7 
SLC7A6 
SLC3A2 
LC: y+LAT-1 
LC: y+LAT-2 
HC: 4F2hc 
LYS, ARG, 
MET, GLN 
Exchanges CAA for 
Na+ and NAA; efflux 
of CAA; y+LAT-2 
may be an 
electroneutral 
ARG/GLN 
exchanger 
Independent 
for CAA; 
dependent for 
NAA 
BLM Mainly in kidney, 
and small intestine; 
also in peripheral 
blood lymphocytes, 
liver, pancreas, testis, 
ovary, placenta, lung, 
thyroid, erythrocytes, 
brain, heart 
b0,+ SLC7A9 
SLC3A1 
LC: b0,+AT 
HC: rbAT 
LYS, ARG, 
LEU, Cystine, 
Ornithine 
Exchanges NAA and 
CAA; influx of CAA 
No Apical Kidney, small 
intestine, heart, liver, 
brain, lung, placenta, 
thymus 
B0,+ SLC6A14 ATB0,+ ALA, LYS, 
ARG, VAL 
Imports NAA and 
CAA 
Yes Apical Trachea, stomach, 
glandular tissues 
1
 Abbrevations: ALA, alanine; ARG, arginine; ATB+, Na+-dependent amino acid transporter; BLM, basolateral membrane; CAA, 
cationic amino acid; CAT, cationic amino acid transporter; GLN, glutamine; HC, heavy chain; LC, light chain; LEU, leucine; LYS, 
lysine; MET, methionine; NAA, neutral amino acid; SLC, solute carrier family; VAL, valine; y+LAT, y+L type amino acid transporter. 
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Figure 1. ARG utilization in T cells.  Abbreviations: ARG, arginine; CAT, cationic 
amino acid transporter; TCR complex, T cell receptor and CD3. 
 
Figure 2. ARG utilization in macrophages.  Abbreviations: ARG, arginine; CAT, cationic 
amino acid transporter; IFN, interferon; iNOS, inducible nitric oxide synthase; IL, 
interleukin; NO, nitric oxide; TGF, transforming growth factor. 
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CHAPTER 2 
Dietary Arginine’s Impact on Arginine Utilization for Immunity 
Introduction 
 
 Nutrition can be utilized to manipulate immune responsiveness to pathogens by 
altering signal transduction in leukocytes, providing substrate for immune cells or 
pathogens, protecting against immunopathology, and influencing gut microbial 
populations and the hormonal environment (1-2).  Nutrients such as vitamins, trace 
minerals, and amino acids are substrates for immunity (1); however, the optimal level of 
supplementation of these nutrients for an animal is often unknown (2).  Therefore, to 
understand the impact of nutrient supplementation on immunocompetence, studies must 
relate nutrient supplementation with the magnitude of leukocyte pools and the function of 
peripheral leukocytes (3).  
 Arginine (ARG) is an immunologic modulator due in part to its role as a substrate 
for the immune system (4).  ARG is an intermediate of the urea cycle and is metabolized 
either by nitric oxide synthase (NOS) to produce nitric oxide (NO) or arginase to produce 
polyamines.  ARG supplementation improves wound healing and improves survival in 
rodent and human tumor models (5).  ARG supplementation (2.8% dietary ARG) of 
wounded rats resulted in faster healing and less postoperative weight loss in comparison 
to those fed a standard commercial diet (1.8% dietary ARG) (6).  In aves, ARG is an 
essential cationic amino acid (CAA) since they are uricotelic and cannot synthesize ARG 
de novo (4-5, 7); however, it is conditionally essential in mammals as it can be 
synthesized from citrulline in the adult kidney (8).  This results in avian immune cells 
being dependent upon acquiring dietary ARG, whereas mammalian immune cells may 
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obtain ARG from either interorgan amino acid metabolism or the diet.  Consequently, in 
addition to growth, dietary ARG levels for immunity must also be considered to ensure 
the immune system is acquiring the ARG it needs.  Therefore, understanding ARG 
utilization by immune cells may help to better understand how ARG needs for immunity 
relate to dietary ARG levels that maximize growth. 
ARG utilization by immune cells has important implications on their function.  In 
T cells, ARG regulates development and function.  For instance, a reduction in 
extracellular ARG in response to surgery, trauma, or sepsis has been associated with a 
decrease in T cell proliferation and cytokine production in vivo (9-11).  In human 
peripheral blood T cells, the absence of ARG blocks in vitro proliferation by arresting 
them in the G0-G1 phase of the cell cycle (11).  Also, the absence of ARG decreases T 
cell CD3ζ chain expression in vitro in Jurkat T cells (12) and interferes with CD3ζ chain 
expression with the T cell receptor (TCR) in activated human peripheral blood T cells 
(9).  In B cells, an ARG deficiency impacts early B cell maturation in the bone marrow of 
transgenic mice at the pro- to pre-B cell transition and decreases the proportion of B cells 
in the lymph nodes and the spleen, but does not impact mature B cell proliferation (8).  In 
monocytes that have become activated tissue macrophages, ARG is a substrate to 
generate effector molecules such as NO.  For instance, in the avian macrophage cell line, 
HD11, production of nitrite was influenced by ARG and lipopolysaccharide (LPS) 
concentration in a dose-dependent manner with no nitrite produced in the absence of 
ARG (7).  Therefore, functional aspects of T cells, B cells, and monocytes are reliant on 
ARG utilization which leads to implications for nutrient supply through nutrient 
transporters.  
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Nutrient transporters for ARG contribute to ARG retention and use in tissues.  
ARG is transported by three gene families (13).  Transport proteins from systems y+ and 
B0,+ import ARG (13-15), while transport proteins from systems y+L and b0,+ export ARG 
(13-14, 16).  In mammalian leukocytes, ARG utilization appears to be primarily mediated 
by gene products encoded for system y+.  For example, stimulated human peripheral 
blood T cells increase system y+ activity, yet only have minimal system y+L activity in 
vitro, (17) while macrophage NO production is dependent upon ARG uptake via cationic 
amino acid transporter-2B (CAT-2B) (15, 18).  Additionally, compared to transport 
through system y+, system y+L transporter mRNA abundance and ARG flux in human 
umbilical vein endothelial cells stimulated with TNF-α and LPS was not significant (19); 
however in murine bone marrow-derived macrophages ARG transport was preferentially 
mediated by system y+L when not activated (20).  In chickens, high affinity CAT 
isoforms in the bursa are more highly expressed than in the thymus (13).  Consequently, 
the number and type of ARG transporters expressed in cells and tissues helps to provide 
an understanding of ARG utilization.  In chickens, the number and types of ARG 
transporters expressed in leukocytes in response to dietary ARG is unknown. 
Therefore, the objective of these experiments was to evaluate the impact of 
dietary ARG supplementation on ARG utilization in peripheral blood mononuclear cells 
(PBMC) and thymocytes in young, growing broiler chicks as they provide a model that is 
not confounded by de novo ARG synthesis.  Two experiments were performed to 
measure: 1) ARG transporters as markers of ARG utilization by PBMC and thymocytes; 
2) thymocyte proliferation as an indication of T cell function in response to dietary ARG; 
and 3) PBMC phenotype. 
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Materials and Methods 
 
2.1. Animals and Diets 
Mixed sex Cobb 500 broilers were obtained from a commercial hatchery (Cedar 
Hatchery, Fresno, CA) and were raised in Petersime brooder batteries (Petersime 
Incubator Co., Gettysburg, OH) contained in an environmentally controlled room (27°C; 
24 h light).  In all experiments, chicks were provided ad libitum access to water and feed.  
In experiment 1, a wheat-soybean meal diet (Table 1) was formulated according to the 
National Research Council (NRC) (21) recommendations, except for arginine (ARG).  
The low ARG diet was analyzed to contain 1.20% ARG and the high ARG diet was 
analyzed to contain 1.35% ARG.  In experiment 2, a corn-soybean meal diet (Table 2) 
was formulated according to NRC (21) recommendations for a young growing broiler 
chick, except for ARG.  Experimental diets were analyzed to contain either 1.1% (low), 
1.3% (adequate) or 1.5% (high) ARG.  All experiments and procedures were approved by 
the California Polytechnic State University Animal Care and Use Committee. 
 
2.2. Experimental Design  
In experiment 1, mixed sex hatchlings (d1) were selected for uniform body weight 
(BW) from a larger population and twelve chicks were placed into one of six replicate 
pens per dietary treatment.  On d3, 7, 14 and 21 posthatch, pen weights were measured 
and three chicks per pen were euthanized by CO2 overdose for whole blood and organ 
collection.  Whole blood from one chick per pen was collected via cardiac puncture into a 
syringe containing a 2% EDTA solution (Sigma-Aldrich, St. Louis, MO; #2854) and four 
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thymic lobes from the chick’s left side were removed aseptically and stored in RPMI 
1640 (MP Biomedicals, LLC, Solon, OH; #1260354) on ice.  From whole blood and 
thymic lobes, respectively, PBMC and thymocytes were isolated to determine ARG 
transporter mRNA abundance.  From the remaining two chicks per pen, four thymic 
lobes from the chick’s left side were removed and weighed.  Spleen and pectoralis major 
and minor were excised from three chicks per pen and weighed. 
In experiment 2, mixed sex hatchlings (d1) were selected for uniform BW from a 
larger population and nine chicks were placed into one of eight replicate pens per dietary 
treatment.  On d10, 14 and 17 posthatch, pen weights were measured and two chicks per 
pen were euthanized by CO2 overdose for whole blood and organ collection.  Whole 
blood from one chick per pen was collected into a heparinized (Hospira, Inc., Lake 
Forrest, IL; #0409-1402-31) syringe and six thymic lobes from the chick’s left side were 
removed aseptically and stored in RPMI 1640 on ice.  From whole blood, PBMC were 
isolated for phenotyping.  From thymic lobes, thymocytes were cultured for a 
proliferation assay.   
 
2.3. Peripheral Blood Mononuclear Cell Isolation 
PBMC were isolated from approximately 3 mL of whole blood.  Whole blood was 
overlaid onto Histopaque-1077 (Sigma-Aldrich, St. Louis, MO; #10771) and centrifuged 
at 350 x g for 15 min at 25°C.  In experiment 1 only, the buffy coat was collected and 
overlaid on iso-volumetric Histopaque-1077 a second time to remove excessive red blood 
cell contamination.  In both experiments, the buffy coat was reconstituted in RPMI 1640 
and centrifuged at 500 x g for 5 min at 25°C.  The pelleted cells were re-suspended in 1 
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mL RPMI 1640 and cells were enumerated with a hemocytometer (experiment 1) or 
ViaCount Reagent (experiment 2; Guava Technologies, Inc, Hayward, CA) per the 
manufacturer’s instructions. PBMC from experiment 1 were aliquoted (4.5 x 106 cells) 
and centrifuged at 500 x g for 5 min at 25°C, snap-frozen in liquid N, and stored at -80°C 
until further analysis.   
 
2.4. Peripheral Blood Mononuclear Cell Phenotyping 
In experiment 2, PBMC phenotype was determined via flow cytometry using the 
EasyCyte Plus System (Guava Technologies, Inc, Hayward, CA) with a 488 nm argon 
laser.  FITC-conjugated mouse anti-chicken CD4, PE-conjugated mouse anti-chicken 
CD8α, FITC-conjugated mouse anti-chicken Bu-1, and PE-conjugated mouse anti-
chicken KUL01 (SouthernBiotech, Birmingham, AL; #8210-02, 8220-09, 8395-02, 8420-
09) were used as markers for CD4+, CD8α+, B cells, and monocytes, respectively.  
Approximately 106 cells were incubated with 0.2 µg (PE) or 1 µg (FITC) antibody for 30 
min at 4°C.  Samples were washed by centrifugation with wash buffer (250 µL PBS, 2% 
BSA, 0.1% NaN3) at 4°C for 5 min at 500 x g.  The cells were then re-suspended in wash 
buffer and diluted 1:10 for analysis.  Lymphocyte and monocyte subpopulations were 
gated by forward and side-scatter characteristics and 5000 gated events were analyzed for 
FITC or PE fluorescence.  The proportions of CD4+, CD8+, Bu-1+, and KUL01+ cell 
populations were expressed as a percentage of gated lymphocytes or gated monocytes, as 
appropriate. 
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2.5. Thymocyte Isolation  
 In experiments 1 and 2, thymic lobes were removed aseptically and placed into 
sterile 60 mm tissue culture plates (Becton-Dickinson, Franklin Lakes, NJ; #353002) 
containing 1.5 mL RPMI 1640 as previously described (22-23).  Briefly, thymic lobes 
were minced gently with forceps to release thymocyte populations into the media.  The 
media from each sample was filtered through a sterile 70-µm nylon cell strainer (BD 
Falcon, Bedford, MA; #352350) and thymocyte concentration was determined with a 
hemocytometer (experiment 1) or ViaCount Reagent per the manufacturer’s protocol 
(experiment 2).  Thymocytes from experiment 1 were aliquoted (2 x 107 cells) and 
pelleted at 500 x g for 5 min at 25°C, snap-frozen in liquid N, and stored at -80°C until 
further analysis.   
 
2.6. Thymocyte Proliferation 
Thymocytes (5 x 105 cells) were cultured in complete media (RPMI 1640, 5% 
FBS, 1% Penicillin/Streptomycin) in each well of two sterile 96-well flat bottom plates 
(BD Falcon, Bedford MA; #353072) with either 0 (control) or 30 µg/mL 
phytohemagglutinin-P (PHA-P; Sigma, St. Louis, MO; #L1668) as previously described 
(23).  Thymocyte proliferation was determined after 48 h using Cell Proliferation ELISA, 
BrdU (colorimetric) (Roche Diagnostics, Indianapolis, IN; #11647229001) per the 
manufacturer’s instructions.  Data was expressed as absorbance at 370 nm. 
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2.7. Total RNA Isolation and Quantitative Real-Time PCR 
Total RNA was isolated from PBMC and thymocyte samples using the NucleoSpin RNA 
II kit (Macherey-Nagel, Bethlehem, PA; #740955.50) per the manufacturer’s instructions. 
Samples were homogenized with a Tissuemiser homogenizer (Fisher Scientific, 
Pittsburgh, PA).  Optical density at 260 nm was used to quantify RNA concentrations.  
PBMC and thymocyte total RNA (250 ng) was reverse transcribed to cDNA using iScript 
cDNA Synthesis Kit (Biorad, Hercules, CA; #170-8891) per the manufacturer’s protocol.  
Quantitative real-time PCR analysis of target gene mRNA abundance was performed 
with the 7500 Fast Real-Time PCR System (Applied Biosystems, Foster City, CA).  
Reactions utilized Fast SYBR Green Master Mix (Applied Biosystems, Foster City, CA; 
#4385610), 1 µL of RT product, and 10 µmol/L of each primer (Table 3).  Thermal 
cycling parameters were 1 cycle of enzyme activation at 95°C for 20 s and 40 cycles of 
denaturing at 95°C for 3 s and annealing and extending at 60°C for 30 s.  Melting curve 
analysis was performed after 40 cycles to confirm product specificity such that melt-
curve analyses containing a specific product peak and primer dimer peak were excluded 
from analysis and considered to be below the limit for accurate detection.  Melting curve 
analysis was performed at 95°C for 15 s, 60°C for 60 s, followed by a linear temperature 
increase of 0.5°C/s to 95°C while continuously monitoring fluorescence.  The change in 
sample mRNA abundance was calculated using the ∆-∆ equation with modifications as 
previously described (22).  Sample PCR amplification efficiencies were determined in the 
log-linear phase with LinRegPCR program (24).  Target gene mRNA abundance was 
normalized by geometric averaging of raw non-normalized values of β-actin, HPRT, and 
TATA box binding protein using geNorm software (25).  Data are presented as the 
44 
 
normalized fold-change in mRNA abundance relative to 1.20% ARG on d7 for 
thymocytes or d3 for PBMC. 
 
2.8. Statistical Analysis  
Dependent variables were analyzed by general linear model (JMP Software, SAS 
Inc, Cary, NC) using either a one-way or two-way analysis of variance (ANOVA).  A 
one-way ANOVA was used to determine the effect of dietary ARG on BW, rate of gain, 
feed intake, and feed efficiency.  A two-way ANOVA was used to determine the main 
effects of dietary ARG level, day, and their interaction on tissue weights, PBMC and 
thymocyte cell concentrations, PBMC phenotype, thymocyte proliferation, and ARG 
transporter mRNA abundance.  When main effects or their interactions were significant 
(P<0.05), means were compared by student’s T pairwise comparisons.  PBMC 
phenotyping data was transformed using arcsine in order to meet conditions for ANOVA.  
Data are reported as nontransformed means and pooled standard errors. 
 
Results 
2.9. Experiment 1 
 
2.9.1. Performance and Tissue Weights 
 Dietary ARG did not affect performance (P>0.05; Table 4) or tissue weights 
(Table 5); however, body weight (BW) and tissue weights increased with age (P<0.05).  
Thymus, spleen, and pectoralis weights increased from d3 to d21 posthatch (P<0.05).  
When organ weights were corrected for individual body weight (relative tissue weights) 
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from d3 to d21 (P<0.05), thymus, spleen, and pectoralis relative weights increased 84%, 
49%, and 451%, respectively. 
 
2.9.2. Peripheral Blood Mononuclear Cell and Thymocyte Concentrations 
PBMC concentration increased approximately 145% from d3 to d7 (P<0.05; 
Table 6) and remained constant through d21.  From d3 to d21 posthatch, thymocyte 
concentration was dependent upon the dietary ARG level (P<0.05; Figure 1).  Between 
d14 and d21, both 1.20% and 1.35% dietary ARG increased the concentration of 
thymocytes; however, at d21, thymocyte concentration at 1.20% dietary ARG was 25% 
higher than at 1.35% dietary ARG (P<0.05). 
  
2.9.3. ARG Transporter mRNA Abundance 
In PBMC, the mRNA of several ARG transporters including CAT-1, CAT-3, 
y+LAT-1, y+LAT-2 and ATB0,+, was detected while the mRNA of CAT-2A and CAT-2B 
was not detected and b0,+AT mRNA was below the limit for accurate detection. When 
data were expressed relative to CAT-1 mRNA abundance on d7 from chicks fed 1.20% 
ARG, both 1.20% and 1.35% dietary ARG decreased CAT-1 mRNA abundance between 
d7 and d14; however, on d7 CAT-1 mRNA abundance at 1.35% ARG was 2-fold higher 
than at 1.20% ARG (Table 7).  In PBMC, CAT-1 and y+LAT-2 mRNA had the highest 
abundance while y+LAT-1 mRNA had the lowest, regardless of dietary ARG level or age 
(Table 7).  
In thymocytes, the mRNA of ARG transporters including CAT-1, CAT-3, 
y+LAT-1, y+LAT-2, and ATB0,+ was detected while the mRNA of CAT-2A and CAT-2B 
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was not detected and b0,+AT mRNA was below the limit for accurate detection.  In 
thymocytes, y+LAT-2 had the highest mRNA abundance while y+LAT-1 had the lowest 
mRNA abundance, regardless of dietary ARG level or age (Table 8).   
Dietary ARG did not change the mRNA abundance of CAT-1, CAT-3 and ATB0,+ 
in thymocytes (P>0.05; Table 8); however, y+LAT-1 mRNA abundance tended (P=0.08) 
to be lower in thymocytes from chicks fed 1.20% ARG.  Thymocyte CAT-1, CAT-3 and 
y+LAT-1 mRNA abundance decreased 47%, 51%, and 68%, respectively, from d3 to d21 
(P<0.05; Table 8). Thymocyte y+LAT-2 mRNA abundance was dependent upon the 
dietary ARG level (P<0.05; Table 8).  Between d3 and d14, 1.20% ARG increased 
thymocyte y+LAT-2 mRNA abundance 2.5-fold (P<0.05) while 1.35% ARG did not 
increase y+LAT-2 mRNA abundance during this time period. 
 
2.10. Experiment 2 
 
 2.10.1. Performance   
Chicks fed 1.5% ARG had 6.4% higher BW compared to chicks fed 1.1% ARG 
(P<0.05; Table 9).  Chicks fed 1.1% or 1.5% ARG consumed less feed than chicks fed 
1.3% ARG (P<0.05).  Feed conversion of chicks fed 1.5% and 1.3% dietary ARG was 
approximately 2.4% lower than that of chicks fed 1.1% dietary ARG (P<0.05).   
 
 2.10.2 Peripheral Blood Mononuclear Cell Concentration 
The concentration of PBMC did not change in response to dietary ARG; however, 
the concentration of viable PBMC increased approximately 35% from d10 to d14 
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(P<0.05; Table 10).  The concentration of apoptotic PBMC increased 97% from 5.28 x 
105 cells/mL to 1.04 x 106 cells/mL between d10 and d17 (P<0.05; Table 10).  The 
concentration of dead PBMC increased 51% from d10 to d14 (P<0.05; Table 10).     
 
2.10.3. Peripheral Blood Mononuclear Cell Phenotyping 
There was no significant effect of dietary ARG or age on percent CD4+ PBMC 
(P>0.05; Table 11).  The ratio of CD4+:CD8+ cells in peripheral blood was not impacted 
by dietary ARG (P>0.05; Table 11).  The percentage of CD8+ PBMC was highest on d17, 
increasing 42% from levels on d14 (P<0.05; Table 11).  There tended (P=0.06) to be an 
age by ARG interaction for the percentage of peripheral blood B cells.  On d17, the 
percentage of B cells was numerically greater from chicks fed 1.5% ARG compared to 
those fed 1.1% and 1.3% ARG.  The percentage of monocytes in peripheral blood at a 
given age was dependent upon dietary ARG (P<0.05; Figure 2).  On d14, the percentage 
of monocytes from chicks fed 1.1% and 1.3% ARG was lower than levels from chicks 
fed 1.5% ARG (P<0.05), but not on d10 or d17 (P>0.05). 
 
2.10.4. Thymocyte Concentration 
The concentration of thymocytes did not depend on dietary ARG levels (P>0.05) 
but did differ by day posthatch (P<0.05; Table 12).  From d10 to d17, the concentration 
of viable and dead thymocytes increased 180% and 312%, respectively, while the 
concentration of apoptotic thymocytes increased 125% from d14 to d17 (P<0.05), but not 
from d10 to d14 (P>0.05). 
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2.10.5. Thymocyte Proliferation 
Thymocyte proliferation was dependent upon dietary ARG at d10 posthatch 
(Table 13).  On d10, 1.5% ARG reduced thymocyte proliferation compared to 1.1% and 
1.3% ARG (P<0.05).  PHA-P addition increased thymocyte proliferation 132%, 45%, 
and 19% on d10, 14, and 17, respectively, compared to controls (P<0.05). 
 
Discussion 
Dietary nutrient requirements for growth may differ from nutrient requirements 
for immunity.  Therefore, in the case of ARG, an immune cell substrate, dietary levels 
were provided at 1.1%, 1.20%, 1.3%, 1.35%, and 1.5% to determine if the resulting 
differences in growth rates might impact ARG use by the immune system.  To assess 
ARG use by the immune system, the genes coordinating ARG uptake (CAT1-3, b0,+AT, 
and ATB0,+) and ARG release (y+LAT-1/2) were measured in quiescent (PBMC) and 
developing immune cells (thymocytes).  In addition, leukocyte numbers, function, and 
type were also measured in order to determine the effect of dietary ARG level on the 
magnitude and characterization of leukocyte pools.  Taken together, the results from 
these studies indicate that the immune system has a number of redundant pathways for 
ARG acquisition and retention and that the effect of dietary ARG on immunity is both 
age and leukocyte dependent. 
Primary and secondary lymphoid organs play a critical role in the development 
and function of the immune system (26).  In the present study, the thymus was selected as 
a marker for primary immune tissue while the spleen was selected as a marker for 
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secondary lymphoid tissues.  Thymus and spleen weights are often times measured as 
indicators of health and immunological stress (5).  Thymic weight is assumed to relate to 
the magnitude of developing T cells whereas spleen weight is assumed to relate to the 
proliferation of immune cells within this secondary lymphoid tissue during periods of 
infection (27-28).  Lymphoid organ weights increased with age, though at a much slower 
rate than pectoralis, but lymphoid organ weights were not altered by dietary ARG levels 
examined in these studies.  Kidd et al. (4) reported that feeding ARG at levels similar to 
(1.48%) and above (1.68%) those used in the present studies also did not alter thymus or 
spleen relative body weights.  Taken together, these results indicate that at the tissue level 
dietary ARG levels from 1.20% to 1.68% may be in excess of the requirement for 
maximizing lymphoid mass.  However, despite no change in thymus mass, 1.20% dietary 
ARG resulted in the greatest thymocyte concentration while 1.1% ARG resulted in the 
greatest thymocyte proliferation, suggesting that current NRC requirements for ARG are 
sufficient for developing T cells.  Nonetheless, since dietary ARG’s impact at the cellular 
level was not identified at the tissue level, lymphoid organ weights alone may not be a 
sensitive indicator of dietary ARG’s needs by the immune system. 
PBMC include T cells, B cells, and monocytes and their measurement allows for 
assessment of both adaptive and innate immunity.  In contrast to developing T cells, the 
metabolic activity of PBMC are low since these cells are in the G0 phase of the cell cycle 
and are not proliferating or synthesizing effector molecules (29).  In healthy animals, 
PBMC concentrations do not indicate infection as in sick animals, but they do indicate 
the type of cells available for recruitment to the spleen, lymph nodes, or site of injury to 
respond to an immune challenge.  Additionally, leukocytes require energy and nutrients 
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to support basal metabolism (30), so PBMC concentration may indicate aberrations in 
nutrient supply.  For instance, in nutrient deficiencies such as protein-energy deficiencies, 
PBMC concentrations decline (31).  Therefore, in the present studies, though the isolation 
procedure may underestimate the concentration of dead PBMC, PBMC concentration 
was determined to analyze ARG needs for maintaining circulating leukocyte 
concentrations.  In the present studies, PBMC concentration was determined to analyze 
ARG needs for maintaining circulating leukocyte concentrations.  PBMC concentrations 
were not responsive to any dietary ARG level examined and this may be due to low rates 
of protein synthesis for “housekeeping” functions in these cell types (30, 32-33).  
Therefore, the present studies indicate that dietary ARG levels as low as 1.1%, levels 
well below that needed for maximum growth, may be adequate for maintaining PBMC 
concentrations.  
In broiler chicks, ARG transporters CAT-1, CAT-3, y+LAT-1, y+LAT-2 and 
ATB0,+ were expressed in PBMC and thymocytes, but CAT-2 and b0,+AT were below the 
limit of detection.  The mRNA abundance for CAT-1 and y+LAT-2 was highest in both 
of these cell types, suggesting that these are the primary transporters involved in ARG 
utilization by PBMC and thymocytes.  In mammalian leukocytes, ARG utilization by 
monocyte/macrophages has major implications on NO production by these cell types.  In 
both monocyte/macrophages and endothelial cells, ARG utilization for NO production is 
dependent upon the induction of the low-affinity, high velocity CAT-2 transporter (15, 
34).  Since the CAT-2 gene is only used for ARG uptake for NO synthesis, other 
transport proteins are presumably responsible for ARG uptake and use for other 
metabolic purposes, such as protein synthesis.  In the case of y+LAT-1and y+LAT-2, their 
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associated heavy chain (4F2hc) has also been found on activated peripheral blood B cells, 
T cells, monocytes and tissue macrophages as a surface antigen (CD98hc) and is 
suggested to have a role in cellular activation activities such as T cell proliferation (35) 
which utilizes ARG (36).  Furthermore, it is suggested that CD98hc directs the light 
chains (y+LAT-1/2) to the plasma membrane and may have a role in amino acid sensing 
(35) which may indicate a role of CD98hc in unstimulated PBMC through its amino acid 
transport capacity.  Since ARG is an essential amino acid in aves, the redundancy of 
ARG transporters in leukocytes may help to ensure that these cell types obtain adequate 
dietary ARG.  
The mRNA abundance of the majority of ARG transporters measured in both 
PBMC and thymocytes decreased over the first three weeks posthatch, suggesting a 
decreased ability to acquire cationic amino acids during this life stage.  This in contrast to 
pectoralis, gastrocnemius, heart, and liver tissues that increased CAT-1, CAT-2, and 
CAT-3 mRNA abundance over the first two weeks posthatch (13).  Therefore, the 
decrease in mRNA abundance of ARG transporters in PBMC and thymocytes and 
increase in ARG transporter expression in skeletal muscle may result in these immune 
cells being at a disadvantage for obtaining dietary ARG in the first few weeks of life.  
Though the increase in ARG transporter expression in skeletal muscle is important to 
maximize protein synthesis for growth, if it is achieved at the expense of generating an 
immune cell repertoire there may be important implications for immunity; however, 
PBMC and thymocyte concentrations in the present studies were maintained or increased 
over this time period suggesting these cells are able to tolerate a decreased ability to 
acquire ARG compared to skeletal muscle.  
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In the present studies, dietary ARG levels in excess of the growth requirement 
increased the mRNA abundance of an ARG importer (CAT-1) in PBMC’s and decreased 
the mRNA abundance of an ARG exporter (y+LAT-2) in thymocytes.  These changes in 
ARG importers and exporters suggest that more ARG may be available for utilization by 
PBMC and thymocytes when dietary ARG levels are in excess of the growth 
requirement.  In comparison, dietary ARG’s impact on ARG transporters in mammalian 
leukocytes is unknown.  However, it is known that general amino acid supply regulates 
amino acid transport (37), and that mammalian CAT-1 translation is responsive to both a 
deprivation of a single essential amino acid or of total amino acids (38).  Therefore, it 
would be expected that ARG supplementation would impact ARG transport in 
mammalian leukocytes thereby altering ARG availability for immunity.  Consequently, 
this hypothesis could be tested experimentally in leukocytes since ARG transporters have 
been extensively characterized in other mammalian tissues.  
Differences in the phenotype of leukocytes in peripheral blood in response to 
dietary nutrients may promote specific types of immune responses.  When considering 
dietary ARG, the percentages of monocytes and B cells were both increased by 1.5% 
ARG, suggesting that dietary ARG levels may bolster both innate and humoral immune 
responses in healthy chicks.  For monocytes, the mechanism by which ARG may regulate 
their percentage in peripheral blood may act as monocytes are released from bone 
marrow (39) and mature in circulation.  For B cells, since they are released from the 
bursa in growing chicks (40) and since ARG deficiency arrests B cells in the pro- to pre- 
B cell transition (8), ARG may be regulating the percentage of B cells in peripheral blood 
by affecting B cell maturation.  In the case of vaccinated broiler chicks, dietary ARG 
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supplementation at 2.2% ARG compared to 1.2% ARG increased the proportion of B 
cells in peripheral blood 9 d after vaccination (41) supporting the idea that dietary ARG 
level may affect humoral immunity.  Consequently, PBMC phenotype in this study 
indicates that dietary ARG supplementation at 1.5% increases the abundance of 
monocytes and B cells in peripheral blood.   
T cells are crucial in coordinating immune responses so nutrient supplementation 
that bolsters their populations in peripheral blood may influence this function; however, 
when supplemented with dietary ARG in healthy chicks, the percentage of CD4+ T, CD8+ 
T cells and the ratio of CD4:CD8 cells in peripheral blood were not altered. Vaccinated 
broiler chicks fed 1.2% or 2.2% dietary ARG also did not alter the percentage of CD4+ T 
cells in PBMC’s; however, CD8+ T cells were numerically higher in birds supplemented 
with 2.2% ARG compared to 1.2% ARG (41).  Taken together, this indicates that 
peripheral blood CD4+ and CD8+ T cell populations in healthy chicks are not responsive 
to ARG.  However, during an immune response dietary ARG levels may promote T 
helper 1 responses due to elevated CD8+ T cells which could be indicated by cytokine 
profiles in plasma or secondary lymphoid organs.  
In summary, these experiments indicate that dietary ARG requirements for 
growth may not be sufficient for ARG utilization by the immune system for some 
parameters.  In the case of ARG transporter mRNA abundance and leukocyte phenotype, 
ARG levels above the NRC requirement may be beneficial for ARG utilization and 
leukocyte abundance in peripheral blood.  Additionally, ARG transporter mRNA 
abundance indicates that the immune system has redundant pathways for ARG 
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acquisition and retention in both quiescent (PBMC) and proliferating (thymocytes) 
leukocytes.   
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Table 1. Composition of diets fed to growing broiler chicks in experiment 1 
 Low Dietary ARG High Dietary ARG 
Ingredient (g/kg)   
Wheat 626.8 626.8 
Soybean Meal 158.6 158.6 
Safflower Meal 90.0 90.0 
Vegetable Oil 66.1 66.1 
Dicalcium Phosphate 18.3 18.3 
Calcium Carbonate 16.2 16.2 
L-Lysine-HCl 5.5 5.5 
Salt 3.4 3.4 
DL-Methionine 3.4 3.4 
Vitamin-mineral premix1 2.5 2.5 
L-Leucine 2.0 2.0 
L-Arginine-HCl - 2.0 
L-Threonine 1.8 1.8 
L-Cystine 1.6 1.6 
Rice Hulls 1.3 1.3 
L-Valine 1.2 1.2 
Copper Sulfate 1.0 1.0 
L-Isoleucine 0.3 0.3 
L-Tryptophan 0.01 0.01 
Analyzed Composition   
ME, kcal/kg (calculated) 3058 3058 
Crude protein, % 18.86 19.35 
Crude fat, % 7.41 8.50 
Arg, % 1.21 1.34 
Lys, % 1.21 1.22 
Met, % 0.61 0.58 
1
 Vitamins and trace minerals were provided as described in the NRC Standard Reference 
Diet for Chicks (21); Vitamin-mineral premix provided in g/kg of diet: choline chloride, 
0.303; folic acid, 0.0004; niacin, 0.033; pantothenic acid, 0.011; riboflavin, 0.0044; 
thiamine-HCl, 0.0011; pyridoxine-HCl, 0.0022; menadione, 0.001; vitamin B12, 
0.000009; Cu, 0.0051; I,0.0025; Fe, 0.045; Mn, 0.066;  Se, 0.0002; Zn, 0.06; Ca, 0.375; 
P, 0.0003; Mg, 0.0033; K, 0.0026; S, 0.026; Cl-, 0.0015; vitamin A supplement, 0.0025; 
vitamin D3 supplement, 0.000083; vitamin E supplement, 0.0138.
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Table 2.  Composition of diets fed to growing broiler chicks in experiment 2 
 Low Dietary 
ARG 
Adequate Dietary 
ARG 
High Dietary 
ARG 
Ingredient (g/kg)    
Corn 483.7 483.7 483.7 
Soybean Meal 139.5 139.5 139.5 
Corn Gluten Meal 113.2 113.2 113.2 
Alfalfa Meal 112.4 112.4 112.4 
Wheat Millrun 58.1 58.1 58.1 
Vegetable Oil 45.0 45.0 45.0 
Dicalcium Phosphate 16.6 16.6 16.6 
Limestone 12.6 12.6 12.6 
L-Arginine-HCl - 2.5 5.0 
L-Lysine-HCl 6.5 6.5 6.5 
Salt 4.1 4.1 4.1 
DL-Methionine 1.4 1.4 1.4 
Choline Chloride 4.8 4.8 4.8 
Vitamin Premix1 0.7 0.7 0.7 
Mineral Premix1 0.7 0.7 0.7 
L-Threonine 0.6 0.6 0.6 
Analyzed Composition    
ME, kcal/kg (calculated) 3080 3080 3080 
Crude protein, % 22.24 22.96 23.68 
Crude fat, % 6.01 6.01 6.01 
Arg, % 1.12 1.31 1.53 
Lys, % 1.35 1.35 1.34 
Met, % 0.50 0.51    0.51 
1
 Vitamins and trace minerals were provided as described in the NRC Standard Reference 
Diet for Chicks (21). 
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Table 3.  Primer sequences for quantitative real-time PCR for chicken ARG transporters 1 
Target Primer Sequence PCR product 
(bp) 
Genbank Accession 
Number 
b0,+AT F    5’-TGAGTGAAGGAAAGGAGAAATTAAGAC-3’ 
R    5’-CCAGGATGACAGAAGTGTAGGC-3’ 
309  
ATB0,+ F    5’-CATACACACTGATGTTGGCATTAGC-3’ 
R    5’-AAGCAATCTGACCACGGAAGC-3’ 
241  
y+LAT-1 F    5’-GTTGGAGCCAGAGAAGGACATC-3’     
R    5’-AAGCCAGTAGTTGAAGCAGTAGTAG-3’ 
165 XM_418326 
y+LAT-2 F    5’-TTGTTCTCTTATTCTGGTTGGGATAC-3’ 
R    5’-TTGGCATAGACACAGCAATAGC-3’ 
100 XM_001231336 
CAT-1 F    5’-ACCTGCCATCGTCATCTCCTTC-3’ 
R    5’-AAGTCTTCAATGTGCCCACCTATG-3’ 
252 EU360441 
CAT-2A F    5’-TGCTTTGTCTACAAGTCTTCTCG-3’ 
R    5’-AATGCCATAATACCAGAGATGACC-3’ 
165 EU360448 
CAT-3 F    5’-CCACGGGCACCAAACAGAAG-3’ 
R    5’-CAGTCAGCACCACGCAGATG-3’ 
150 XM_420204 
β-actin F    5’-ACCCCTGTGATGAAACAAAACCC-3’ 
R    5’-GCGAGTAACTTCCTGTAACAATGC-3’ 
265 NM_205518 
HPRT F    5’-GCCAGACTTTGTTGGATTTGAAG-3’ 
R    5’-AGAGTTGAAGCCTGTGAGAGATAG-3’ 
213 NM_204848 
TATA BP F    5’-TTTAGCCCGATGATGCCGTATG-3’ 
R    5’-CTGTGGTAAGAGTCTGTGAGTGG-3’ 
196 NM_205103 
1 Abbreviations: ARG, arginine; ATB+, Na+-dependent amino acid transporter; bp, base pairs; CAT, cationic amino acid transporter; 
y+LAT, y+L type amino acid transporter. 
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Table 4. Broiler performance in response to 1.20% or 1.35% dietary ARG fed from d1 to 
d21 posthatch 1,2 
 
1.20% ARG 1.35% ARG SEM P-value 
Body weight, g 285.50 297.05 49.64 0.8699 
Feed intake, g/c*d 37.23 37.24 0.96 0.9924 
Gain, g/c*d 33.25 35.25 0.95 0.1668 
Feed conversion, 
g Feed intake/g BW gain 
1.12 1.06 0.03 0.1540 
1
 Values are means ± pooled SEM (n=6). A wheat-soybean meal diet formulated 
according to the NRC, except for ARG was fed.   
2
 Abbreviations: ARG, arginine; BW, body weight; c, chick; d, day; g, gram.
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Table 5. Tissue weights from broiler chicks fed 1.20% or 1.35% dietary ARG from d1 to d21 posthatch 1,2 
 1.20% ARG 1.35% ARG  P-value 
 d3 d7 d14 d21 d3 d7 d14 d21 SEM ARG Day ARG X Day 
Thymus, g 0.077 0.184 0.546 1.091 0.066 0.208 0.497 1.213 0.062 0.6547 <0.0001 0.5657 
Thymus, 
%BW 
0.088 0.113 0.133 0.146 0.079 0.125 0.120 0.160 0.010 0.9024 <0.0001 0.3901 
Spleen, g 0.067 0.166 0.378 0.811 0.062 0.181 0.396 0.866 0.033 0.3772 <0.0001 0.8379 
Spleen, %BW 0.078 0.099 0.094 0.109 0.071 0.113 0.094 0.111 0.008 0.6461 0.0001 0.6569 
Pectoralis, g 1.78 11.74 37.06 85.77 1.87 11.97 36.71 89.73 1.73 0.4424 <0.0001 0.5853 
Pectoralis, 
%BW 
2.03 6.99 9.06 11.58 2.16 7.16 8.86 11.50 0.20 0.9473 <0.0001 0.7530 
1
 Values are means ± pooled SEM (n=6). 
2
 Abbreviations: ARG, arginine; BW, body weight; d, day; g, gram. 
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Table 6. Mean cell concentrations of PBMC isolated from broiler chicks fed 1.20% or 1.35% dietary ARG 1,2 
 1.20% ARG 1.35% ARG  P-value 
 d3 d7 d14 d21 d3 d7 d14 d21 SEM ARG Day ARG X Day 
PBMC 
(107/mL) 
1.563 3.417 3.717 4.342 1.261 3.508 3.217 3.542 0.964 0.5539 <0.05 0.9692 
1
 Values are means ± pooled SEM (n=6). 
2
 Abbreviations: ARG, arginine; d, day; PBMC, peripheral blood mononuclear cell. 
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Table 7. Mean mRNA abundance of ARG transporters relative to CAT-1 in PBMC from broiler chicks fed 1.20% or 1.35% dietary 
ARG 1,2 
 1.20% ARG 1.35% ARG  P-value 
 d7 d14 d21 d7 d14 d21 SEM ARG Day ARG X Day 
CAT-1 1.000b 0.230c 0.297c 2.020a 0.515c 0.264c 0.146 0.0013 <0.01 <0.01 
CAT-3 1.192 0.171 0.210 1.379 0.366 0.129 0.228 0.5948 <0.01 0.7888 
y+LAT-1 1.179 0.023 0.018 0.922 0.010 0.017 0.289 0.6884 <0.01 0.8812 
y+LAT-2 1.114 1.388 1.763 1.024 1.897 1.239 0.260 0.8689 0.1013 0.1642 
ATB0,+ 1.109 0.218 0.163 0.697 0.171 0.050 0.231 0.3161 <0.01 0.7113 
1
 Values are means ± pooled SEM (n=6). Data are expressed relative to CAT-1 mRNA abundance on d7 from chicks fed 1.20% ARG. 
Means within a row not sharing a common superscript differ (P<0.05). 
2
 Abbreviations: ARG, arginine; ATB+, Na+-dependent amino acid transporter; CAT, cationic amino acid transporter; d, day; y+LAT, 
y+L type amino acid transporter; PBMC, peripheral blood mononuclear cell.  
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Table 8. Mean mRNA abundance of ARG transporters relative to CAT-1 in thymocytes from broiler chicks fed 1.20% or 1.35% 
dietary ARG 1,2 
 1.20% ARG 1.35% ARG  P-value 
 d3 d7 d14 d21 d3 d7 d14 d21 SEM ARG Day ARG X Day 
CAT-1 1.000 0.761 0.698 0.544 0.858 0.718 0.430 0.442 0.131 0.1310 <0.01 0.8514 
CAT-3 0.992 0.588 0.618 0.457 0.820 0.450 0.592 0.425 0.111 0.2363 <0.001 0.8830 
y+LAT-1 0.999 0.437 0.307 0.520 1.913 0.686 0.544 0.424 0.250 0.0767 <0.001 0.2474 
y+LAT-2 2.352c 3.317bc 6.054a 3.129bc 3.858bc 4.494ab 3.152bc 2.660bc 0.722 0.7384 0.0806 <0.05 
ATB0,+ 1.626 1.136 0.772 1.737 1.815 0.479 1.298 1.651 0.538 0.8205 0.2936 0.7721 
1
 Values are means ± pooled SEM (n=6). Data are expressed relative to CAT-1 mRNA abundance on d3 from chicks fed 1.20% ARG. 
Means within a row not sharing a common superscript differ (P<0.05).  
2
 Abbreviations: ARG, arginine; ATB+, Na+-dependent amino acid transporter; CAT, cationic amino acid transporter; d, day; y+LAT, 
y+L type amino acid transporter.
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Table 9. Broiler performance in response to 1.1%, 1.3% or 1.5% dietary ARG from d1 to 
d17 posthatch 1,2 
 1.1% ARG 1.3% ARG 1.5% ARG SEM P-value 
Body weight, g 524.88b 567.00a 560.75a 9.53 <0.05 
Feed Intake, g/c*d 37.61b 38.95a 37.59b 0.41 <0.05 
Gain, g/c*d 28.37b 30.84a 30.48a 0.56 <0.05 
Feed conversion,  
g Feed intake/g BW 
gain 1.33a 1.27b 1.24b 0.02 
 
<0.05 
1
 Values are means ± pooled SEM (n=8). Means within a row not sharing a common 
superscript are significantly different (P<0.05). 
2
 Abbreviations: ARG, arginine; BW, body weight. 
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Table 10. Mean cell concentrations of PBMC isolated from broiler chicks fed 1.1%, 1.3%, or 1.5% dietary ARG on d10, 14, and 17 
posthatch 1,2 
 1.1% ARG 1.3% ARG 1.5% ARG  P-value 
PBMC 
(108/mL) 
d10 d14 d17 d10 d14 d17 d10 d14 d17 SEM ARG Day ARG X Day 
Viable  0.823 0.931 1.162 0.814 1.109 1.299 0.837 1.288 1.230 0.085 0.1115 <0.0001 0.2587 
Apoptotic 0.006 0.006 0.009 0.004 0.010 0.011 0.006 0.008 0.011 0.001 0.2563 <0.0001 0.1428 
Dead 0.018 0.020 0.019 0.017 0.032 0.020 0.017 0.027 0.027 0.004 0.3302 <0.05 0.2466 
1
 Values are means ± pooled SEM (n=8). 
2
 Abbreviations: ARG, arginine; d, day; PBMC, peripheral blood mononuclear cell. 
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Table 11. PBMC phenotyping of cells isolated from broiler chicks fed 1.1%, 1.3%, or 1.5% dietary ARG on d10, 14, and 17 posthatch 
1,2
 
 1.1% ARG 1.3% ARG 1.5% ARG  P-value 
 d10 d14 d17 d10 d14 d17 d10 d14 d17 SEM ARG Day ARG X Day 
%CD4+  10.18 8.39 8.77 10.51 9.71 9.66 8.81 9.74 10.21 1.20 0.7569 0.8375 0.7552 
%CD8+ 4.78 3.74 4.84 3.98 3.91 5.54 3.42 3.27 5.13 0.69 0.5992 <0.05 0.6752 
CD4:CD8 2.26 2.60 2.15 3.32 2.74 1.77 2.68 3.10 2.17 0.42 0.6123 <0.05 0.4656 
%B cells 2.21 5.40 2.74 4.15 2.26 2.78 2.33 5.09 6.33 1.22 0.5627 0.2026 0.0605 
1
 Values represent means ± pooled SEM (n=8). PBMC phenotype was determined via flow cytometry. Lymphocyte and monocyte 
subpopulations were gated by forward and side-scatter characteristics and 5,000 gated events were analyzed for FITC fluorescence.  
The proportions of CD4+, CD8+, and Bu-1+ cell populations were expressed as a percentage of gated lymphocytes. 
2
 Abbreviations: ARG, arginine; PBMC, peripheral blood mononuclear cell. 
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Table 12. Mean cell concentrations of thymocytes isolated from broiler chicks fed 1.1%, 1.3%, or 1.5% dietary ARG on d10, 14, and 
17 posthatch 1,2 
 1.1% ARG 1.3% ARG 1.5% ARG  P-value 
Thymocytes 
(109/mL) 
d10 d14 d17 d10 d14 d17 d10 d14 d17 SEM ARG Day ARG 
X Day 
Viable  0.581 0.969 1.763 0.743 1.224 1.725 0.670 1.237 2.080 0.126 0.1082 <0.0001 0.4666 
Apoptotic 0.010 0.008 0.028 0.009 0.011 0.023 0.008 0.012 0.019 0.002 0.5530 <0.0001 0.1321 
Dead 0.052 0.113 0.245 0.072 0.141 0.221 0.051 0.137 0.254 0.018 0.7667 <0.0001 0.4811 
1
 Values represent means ± pooled SEM (n=8). 
2
 Abbreviations: ARG, arginine; d, day. 
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Table 13. Mean absorbance of thymocyte proliferation of cells isolated from broiler chicks fed 1.1%, 1.3%, or 1.5% dietary ARG on 
d10, 14, and 17 posthatch 1,2 
  1.1% ARG 1.3% ARG 1.5% ARG  P-value 
Day PHA-P - + - + - + SEM ARG PHA-P ARG X 
PHA-P 
10  0.273 0.662 0.269 0.633 0.221 0.472 0.035 0.0011 <0.0001 0.1091 
14  0.234 0.363 0.244 0.384 0.266 0.337 0.019 0.6848 <0.0001 0.1395 
17  0.231 0.290 0.242 0.297 0.240 0.263 0.016 0.5028 <0.001 0.4603 
1
 Values represent means ± pooled SEM (n=8). 
2
 Abbreviations: ARG, arginine; PHA-P, phytohemagglutinin.
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Figure 1.  Thymocyte concentration on d3, 7, 14, and 21 posthatch from broiler chicks 
fed 1.20% or 1.35% dietary ARG.  Thymocytes were isolated and enumerated as 
described in section 2.5.  Values represent means ± SEM (n=6).  Means not sharing a 
common superscript differ (P<0.05).  Abbreviations: ARG, arginine. 
 
Figure 2.  Peripheral blood mononuclear cell phenotyping of monocytes isolated from 
broiler chicks fed 1.1%, 1.3%, or 1.5% dietary ARG on d10, 14, and 17 posthatch.  
PBMC were isolated and phenotyped by flow cytometry as described in sections 2.3 and 
2.4.  Values represent means ± SEM (n=8).  Means not sharing a common superscript 
differ (P<0.05).  Abbreviations: ARG, arginine; PBMC, peripheral blood mononuclear 
cell. 
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CHAPTER 3: Dietary Arginine’s Impact on the Acute Phase Response 
Introduction 
When the immune system is activated there are alterations in nutrient metabolism 
and nutrient partitioning (1).  For instance, mounting an innate immune response such as 
an acute phase response (APR) initiated by gram negative bacterial lipopolysaccharide 
(LPS) (2) inhibits growth as the APR is nutritionally expensive due to the production of 
hepatic acute phase proteins and the recruitment and proliferation of immune cells (3, 4).  
Therefore, these alterations have implications for nutrient use, such as arginine (ARG), 
that are important substrates for both growth and immune functions.  During the APR, 
ARG is metabolized by inducible nitric oxide synthase (iNOS) to produce nitric oxide 
(NO) in macrophages and is necessary to support increases in immune cell proliferation 
(5-7).  Consequently, ARG supply and utilization during the APR is of great importance 
to immune cells, especially avian immune cells, since aves are uricotelic and do not 
synthesize ARG de novo whereas mammalian immune cells obtain ARG from either 
interorgan amino acid metabolism or the diet. Since ARG and other nutrients must be 
obtained by leukocytes during the APR, LPS also induces immune cells to produce 
cytokines which alter metabolic and physiologic homeostasis (8).      
The APR is generally characterized by proinflammatory cytokines (i.e. IL-1β and 
IL-6) (2, 9); however, many other cytokines help coordinate immune responses.  
Traditionally, in mammals the T1-T2 dichotomy in TH cells is defined by two distinct sets 
of cytokines; TH1 subset cytokines (i.e. IL-18 and IFN-γ) which promote cell-meditated 
immunity and NO production in macrophages and TH2 subset cytokines (i.e. IL-4 and IL-
13) which promote humoral immunity and antibody class switching to isotypes important 
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in allergy and antihelminthic responses; however, only relatively recently was this 
dichotomy expanded to other immune cells (TH3 subset cytokines (i.e. IL-10, TGF-β2, 
and TGF-β4)) and also identified in aves (2, 9-12).  Therefore, cytokine profiles of 
immune tissues can be indicative of the type of immune response.  In accordance with 
cytokine profiles, the shifting population of peripheral blood mononuclear cells (PBMC) 
is also indicative of the type and progression of an immune response.  
PBMC include cells of both the innate (i.e. monocytes) and adaptive (i.e. B and T 
cells) immune system which circulate at maintenance until an immune response is 
provoked.  During an immune challenge, PBMC are primarily recruited to lymph nodes, 
splenic germinal centers, and the site of infection (13).  By determining the proportions of 
these cells in peripheral blood at different time points during an APR they can be used to 
characterize how nutrients such as ARG impact the APR.   
Therefore, ARG’s impact on the severity of the APR was evaluated by 
considering PBMC phenotype and splenic cytokine profiles.  To study ARG’s impact on 
the APR, broiler chicks were used as a model not confounded by de novo ARG synthesis 
allowing for dietary manipulation of ARG supply to immune cells and tissues. 
 
Materials and Methods 
3.1. Animals and Diets 
Mixed sex Cobb 500 broilers were obtained from a commercial hatchery (Cedar 
Hatchery, Fresno, CA) and were raised in Petersime brooder batteries (Petersime 
Incubator Co., Gettysburg, OH) contained in an environmentally controlled room (27°C; 
24 h light).  Chicks were provided ad libitum access to water and feed.  A corn-soybean 
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meal diet (Table 1) was formulated according to National Research Council (NRC) (14) 
recommendations for a young growing broiler chick, except for ARG.  Experimental 
diets were analyzed to contain either 1.1% (low), 1.3% (adequate) or 1.5% (high) ARG.  
All experiments and procedures were approved by the California Polytechnic State 
University Animal Care and Use Committee. 
 
3.2. Experimental Design  
On d19, two chicks from four replicate pens per treatment were not injected 
(control) or injected subcutaneously with Salmonella typhimurium lipopolysaccharide (1 
mg/kg BW; LPS; Sigma, St. Louis, MO; #L7261).  At 2 h and 24 h post-injection, one 
chick per pen was euthanized by cervical dislocation for blood and organ collection.  
Whole blood from one chick per pen was collected into a heparinized syringe (Hospira, 
Inc., Lake Forrest, IL; #0409-1402-31) to isolate PBMC for phenotyping.  Spleen from 
one chick per replicate pen was removed and frozen between aluminum plates in liquid N 
and stored at -80°C until further analysis.  At 2 h and 24 h post-injection, pen weights of 
LPS injected chicks were measured. 
 
3.3. Peripheral Blood Mononuclear Cell Isolation 
PBMC were isolated from approximately 3 mL of whole blood.  Whole blood was 
overlaid onto Histopaque-1077 (Sigma-Aldrich, St. Louis, MO; #10771) and centrifuged 
at 350 x g for 15 min at 25°C.  The buffy coat was reconstituted in RPMI 1640 (MP 
Biomedicals, LLC, Solon, OH; #1260354) and centrifuged at 500 x g for 5 min at 25°C.  
The pelleted cells were re-suspended in 1 mL RPMI 1640 and were enumerated with 
78 
 
ViaCount Reagent (Guava Technologies, Inc, Hayward, CA) per the manufacturer’s 
instructions. 
 
3.4. Peripheral Blood Mononuclear Cell Phenotyping 
PBMC phenotype was determined via flow cytometry using the EasyCyte Plus 
System (Guava Technologies, Inc, Hayward, CA) with a 488 nm argon laser.  FITC-
conjugated mouse anti-chicken CD4, PE-conjugated mouse anti-chicken CD8α, FITC-
conjugated mouse anti-chicken Bu-1, and PE-conjugated mouse anti-chicken KUL01 
(SouthernBiotech, Birmingham, AL; #8210-02, 8220-09, 8395-02, 8420-09) were used as 
markers for CD4+, CD8α+, B cells, and monocytes, respectively.  Approximately 106 
cells were incubated with 0.2 µg (PE) or 1 µg (FITC) antibody for 30 min at 4°C.  
Samples were washed by centrifugation with wash buffer (250 µL PBS, 2% BSA, 0.1% 
NaN3) at 4°C for 5 min at 500 x g.  The cells were then re-suspended in wash buffer and 
diluted 1:10 for analysis.  Lymphocyte and monocyte subpopulations were gated by 
forward and side-scatter characteristics and 5000 gated events were analyzed for FITC or 
PE fluorescence.  The proportions of CD4+, CD8+, Bu-1+, and KUL01+ cell populations 
were expressed as a percentage of gated lymphocytes or gated monocytes, as appropriate. 
 
3.5. Total RNA Isolation and Quantitative Real-Time PCR 
Total RNA was isolated from spleen samples using the NucleoSpin RNA II kit 
(Macherey-Nagel, Bethlehem, PA; #740955.50) per the manufacturer’s instructions. 
Samples were homogenized with a Tissuemiser homogenizer (Fisher Scientific, 
Pittsburgh, PA).  Optical density at 260 nm was used to quantify RNA concentrations.  
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Spleen total RNA (1 µg) was reverse transcribed to cDNA using iScript cDNA Synthesis 
Kit (Biorad, Hercules, CA; #170-8891) per the manufacturer’s protocol.  Quantitative 
real-time PCR analysis of target gene mRNA abundance was performed with the 7500 
Fast Real-Time PCR System (Applied Biosystems, Foster City, CA).  Reactions utilized 
Fast SYBR Green Master Mix (Applied Biosystems, Foster City, CA; #4385610), 1 µL 
of RT product, and 10 µmol/L of each primer (Table 2).  Thermal cycling parameters 
were 1 cycle of enzyme activation at 95°C for 20 s and 40 cycles of denaturing at 95°C 
for 3 s and annealing and extending at 60°C for 30 s.  Melting curve analysis was 
performed after 40 cycles to confirm product specificity such that melt-curve analyses 
containing a specific product peak and primer dimer peak were excluded from analysis 
and considered to be below the limit for accurate detection.  Melting curve analysis was 
performed at 95°C for 15 s, 60°C for 60 s, followed by a linear temperature increase of 
0.5°C/s to 95°C while continuously monitoring fluorescence.  The change in sample 
mRNA abundance was calculated using the ∆-∆ equation with modifications as 
previously described (15).  Sample PCR amplification efficiencies were determined in the 
log-linear phase with LinRegPCR program (16).  Target gene mRNA abundance was 
normalized by geometric averaging of raw non-normalized values of β-actin, HPRT, and 
GAPDH using geNorm software (17).  Data are presented as the normalized fold-change 
in mRNA abundance relative to 1.30% ARG at 2 h post-injection from uninjected chicks. 
 
3.6. Statistical Analysis  
Dependent variables were analyzed by general linear model (JMP Software, SAS 
Inc, Cary, NC) using either a one-way or two-way analysis of variance (ANOVA).  A 
80 
 
one-way ANOVA was used to determine the effect of dietary ARG on rate of gain, feed 
intake, and feed conversion.  A two-way ANOVA was used to determine the main effects 
of dietary ARG level, treatment with LPS, and their interaction on feed intake, PBMC 
cell concentrations, PBMC phenotype, and TH subset cytokine mRNA abundance.  When 
main effects or their interactions were significant (P<0.05), means were compared by 
student’s T pairwise comparisons.  PBMC phenotyping data was transformed using 
arcsine in order to meet conditions for ANOVA.  Data are reported as nontransformed 
means and pooled standard errors. 
 
Results 
3.7. Performance   
Feed intake and gain did not differ between dietary ARG levels (P>0.05; Tables 3 
and 4).  However, dietary ARG tended to impact feed conversion from 0-2 h (P=0.06; 
Table 4).  Also, from 0-2 h, LPS decreased feed intake by 60% compared to controls 
(P<0.05; Table 3), but feed intake was similar to controls from 2-24 h post-LPS injection 
(P>0.05; Table 3). 
 
3.8. Peripheral Blood Mononuclear Cell Concentration 
The concentration of PBMC after LPS injection was not impacted by dietary 
ARG (P>0.05; Table 5).  The concentration of viable PBMC at 2 h was 36% lower in 
chicks injected with LPS compared to controls (P<0.05).  At 24 h post injection, the 
concentration of dead PBMC was 54% higher in LPS injected chicks (P<0.05).  At both 2 
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and 24 h post injection, the concentration of apoptotic PBMC did not differ (P>0.05) in 
response to LPS injection. 
 
3.9. Peripheral Blood Mononuclear Cell Phenotyping 
LPS injection did not alter the percentage of CD4+ T cells, CD8+ T cells, B cells, 
monocytes, and the ratio of CD4+:CD8+ T cells in peripheral blood in response to dietary 
ARG (P>0.05; Table 6).  LPS decreased peripheral blood CD4+ T cells, CD8+ T cells, B 
cells, and monocytes by 46%, 52% 38%, and 82%, respectively, at 2 h post-injection 
(P<0.05; Figure 1), but this decrease was no longer evident at 24 h post injection 
(P>0.05; Table 6).  LPS did not impact the ratio of CD4+:CD8+ T cells (P>0.05; Table 6). 
 
3.10. Cytokine mRNA Abundance 
 Dietary ARG did not alter the mRNA abundance of IL-1β, IL-6, IL-18, IFN-γ, 
TGF-β2, and TGF-β4 after LPS injection at either 2 or 24 h (P>0.05; Table 7).  At 2 h 
post injection, LPS administration increased IL-1β, IL-6 IL-18, IFN-γ, and TGF-β4 
mRNA abundance (P<0.05), but this did not persist at 24 h (P>0.05) except in the case of 
IL-18 mRNA abundance (P<0.05).  There tended (P=0.08) to be a LPS by ARG 
interaction for the mRNA abundance of TGF-β4 at 2 h post LPS administration.  IL-4, 
IL-10, and IL-13 mRNA abundance was low or not detectable at both 2 h and 24 h post 
LPS administration as it was below the level needed for accurate quantification. 
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Discussion 
Activation of the immune system, such as during the APR, results in changes in 
nutrient metabolism (1).  Of the many nutrients metabolized by leukocytes during the 
APR, ARG is of great importance in NO production and leukocyte proliferation.  
Therefore, dietary ARG levels were provided at 1.1%, 1.3%, and 1.5% to determine if 
ARG impacts the severity of the APR initiated by Salmonella typhimurium LPS injection.  
To assess ARG’s impact on the APR, PBMC concentration and phenotype as well as 
splenic cytokine profiles were determined.  Taken together, the results from this study 
indicate that LPS injection results in a rapid APR that may be lessened in severity 
through dietary ARG’s affect on TGF-β4 mRNA abundance. 
During an immune response in growing animals, the decrease in feed intake 
accounts for most of the decline in growth rate while inefficient nutrient metabolism 
accounts for the remainder of the decline (1).  Therefore, nutrient supplementation that 
alleviates this decline in growth is of great interest.  In the present study, LPS injection 
resulted in decreased feed intake typical of the APR (8, 18-21), but the decrease was not 
mitigated by dietary ARG level.  Similarly, Takahashi et al. (22) found that dietary ARG 
levels above (2.44%) and below (0.65%) those in this study did not impact feed intake 
following LPS injection.  Taken together, this indicates that manipulation of dietary ARG 
level is unable to alleviate anorexia induced by the APR.  However, early on in the APR, 
dietary ARG tended to offset negative feed conversion.  Still, feed conversion is 
calculated from feed intake and gain and only accounts for weight loss attributed to 
decreased feed intake.  Therefore, further studies are necessary to determine if this trend 
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has biological meaning concerning dietary ARG’s impact on the growth depression 
associated with the APR.  
Alteration of peripheral blood leukocyte concentration is often used as an 
indicator of health status in humans and animals (23).  In the present study, the rapid 
change in concentration of viable and dead PBMC indicates that the immune system is 
reacting to the LPS injection and indicates that PBMC are quickly recruited from blood to 
the spleen or site of infection.  Additionally, PBMC metabolize nutrients at a basal 
metabolic rate until recruitment and activation when their rate of metabolism and demand 
for nutrients increases (1).  For instance, during the APR, demand increases for some 
amino acids (i.e. phenylalanine, threonine, cysteine) presumably due to acute phase 
protein synthesis, leukocyte proliferation, and mitigation of body nitrogen loss due to 
skeletal muscle catabolism (24-26).  Therefore, since ARG is an amino acid metabolized 
by leukocytes, dietary ARG’s impact on PBMC concentration was utilized to indicate if 
ARG reduces the severity of the APR by maintaining the concentration of PBMC.  
However, in the present study, dietary ARG did not impact PBMC concentration.  
Therefore, ARG may not reduce the severity of the APR by maintaining the 
concentration of PBMC. 
In agreement with PBMC concentration, the percentages of PBMC 
subpopulations decreased in response to LPS injection, but were not impacted by dietary 
ARG as they were in healthy chicks in which peripheral blood monocyte and B cell 
populations were increased by 1.5% dietary ARG (D’Amato and Humphrey, 
unpublished).  This differential affect of ARG may occur because of differences in 
nutrient priority in healthy chicks verses those mounting the APR.  In healthy chicks, 
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ARG may be directed toward regulating the percentage of monocytes and B cells in 
peripheral blood during maturation and as they are released from bone marrow or bursa, 
respectively (27, 28) whereas in chicks mounting an APR, ARG may instead be directed 
toward production of effector molecules (29).  In either case, ARG utilization by 
leukocytes is directed by cytokines. 
LPS injection transiently increases splenic proinflammatory and TH1, but not TH2, 
subset cytokine mRNA abundance.  The increase in proinflammatory and TH1 subset 
cytokines in response to inflammatory stimuli has been previously reported (3, 20, 30, 
31).  Since proinflammatory cytokines are in part responsible for the decline in growth 
associated with the APR (1), dietary ARG may impact splenic cytokine profiles and 
mediate this decline.  However, in the present study, dietary ARG did not alter the 
mRNA abundance of proinflammatory cytokines.  On the other hand, 1.3% dietary ARG 
did tend to increase the expression of TGF-β4 mRNA in LPS-injected chicks.  TGF-β4 is 
the most commonly expressed TGF-β isoform in chickens (31) which may explain why 
this trend was only observed in TGF-β4 and not TGF-β2 mRNA abundance.  TGF-β4 is 
anti-inflammatory and immunosuppressive on activated lymphocytes and 
monocytes/macrophages (2) and is important in suppression of the APR to avoid 
excessive inflammation.  Since ARG tends to impact TGF-β4, dietary ARG 
supplementation may decrease the severity of the APR and alleviate its detriment to 
growth. 
In summary, PBMC concentration and phenotype and splenic cytokine production 
demonstrated that lymphocyte and monocyte populations decreased rapidly following 
LPS injection suggesting emigration to the site of infection or secondary lymphoid 
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tissues.  Also, since adequate dietary ARG levels tended to alleviate negative feed 
conversion and increase the splenic mRNA abundance of the anti-inflammatory cytokine, 
TGF-β4, dietary ARG supplementation may lessen the severity of the APR. 
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Table 1.  Composition of diets fed to growing broiler chicks 
 Low Dietary ARG Adequate Dietary 
ARG 
High Dietary 
ARG 
Ingredient (g/kg)    
Corn 483.7 483.7 483.7 
Soybean Meal 139.5 139.5 139.5 
Corn Gluten Meal 113.2 113.2 113.2 
Alfalfa Meal 112.4 112.4 112.4 
Wheat Millrun 58.1 58.1 58.1 
Vegetable Oil 45.0 45.0 45.0 
Dicalcium Phosphate 16.6 16.6 16.6 
Limestone 12.6 12.6 12.6 
L-Arginine-HCl - 2.5 5.0 
L-Lysine-HCl 6.5 6.5 6.5 
Salt 4.1 4.1 4.1 
DL-Methionine 1.4 1.4 1.4 
Choline Chloride 4.8 4.8 4.8 
Vitamin Premix1 0.7 0.7 0.7 
Mineral Premix1 0.7 0.7 0.7 
L-Threonine 0.6 0.6 0.6 
Analyzed Composition    
ME, kcal/kg 
(calculated) 
3080 3080 3080 
Crude protein, % 22.24 22.96 23.68 
Crude fat, % 6.01 6.01 6.01 
Arg, % 1.12 1.31 1.53 
Lys, % 1.35 1.35 1.34 
Met, % 0.50 0.51    0.51 
1
 Vitamins and trace minerals were provided as described in the NRC Standard Reference 
Diet for Chicks (14). 
91 
 
Table 2.  Primer sequences for quantitative real-time PCR for chicken cytokines 1,2 
Target Primer Sequence PCR product (bp) Genbank Accession Number 
IL-1β F    5’-CACCAACCAACCCGACCAG-3’ 
R    5’-GCAACGGGACGGTAATGAAAC-3’ 
214 NM_204524 
IL-4 F    5’-AGACAAATAACAAAACTGAGC-3’ 
R    5’-TTGGTGGAAGAAGGTACG-3’ 
230 NM_001007079 
IL-6 F    5’-GAAGTGGTCATCCCAGACTCG-3’ 
R    5’-GGTGCATGGTGATTTTCTCTATCC-3’ 
91 AJ309540 
IL-10 F    5’-CATGCTGCTGGGCCTGAA-3’ 
R    5’-CGTCTCCTTGATCTGCTTGATG-3’ 
448 AJ621614 
IL-13 F    5’-CACCCAGGGCATCCAGAA-3’ 
R    5’-TCCGATCCTTGAAAGCCACTT-3’ 
593 AJ621735 
IL-18 F    5’-AGGTGAAATCTGGCAGTGGAAT-3’ 
R    5’-ACCTGGACGCTGAATGCAA-3’ 
94 AJ277865 
IFN-γ F    5’-GTGAAGAAGGTGAAAGATATCATGGA-3’ 
R    5’-GCTTTGCGCTGGATTCTCA-3’ 
712 Y07922 
 
TGF-β2 F    5’-CCCTCCTACAGACTTGAGTCG-3’   
R    5’-CTGCACATTCCTAAAACAATAGGC-3’ 
84 NM_001031045 
TGF-β4 F    5’-AGGATCTGCAGTGGAAGTGGAT-3’ 
R    5’-CCCCGGGTTGTGTTGGT-3’ 
137 M31160 
 
β-actin F    5’-ACCCCTGTGATGAAACAAAACCC-3’ 
R    5’-GCGAGTAACTTCCTGTAACAATGC-3’ 
265 NM_205518 
HPRT F    5’-GCCAGACTTTGTTGGATTTGAAG-3’ 
R    5’-AGAGTTGAAGCCTGTGAGAGATAG-3’ 
213 NM_204848 
GAPDH F    5’-GGTGCTGAGTATGTTGTGGAGTC-3’ 
R    5’-GTCTTCTGTGTGGCTGTGATGG-3’ 
290 NM_204305 
1 Abbreviations: bp, base pairs; IL, interleukin; IFN, interferon; TGF, transforming growth factor. 
2
 Published primers were used for IL-10 (32), IL-13 (10), IL-18 (33), IFN-γ (32), TGF-β4 (32). 
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Table 3. Feed intake of LPS injected chicks fed 1.1%, 1.3%, or 1.5% dietary ARG 1,2  
Feed Intake, g  1.1% ARG 1.3% ARG 1.5% ARG  P-value 
Time, h - LPS + LPS - LPS + LPS - LPS + LPS SEM ARG LPS ARG X LPS 
0 – 2 3.46 2.00 2.50 1.13 5.25 1.38 0.72 0.1584 <0.01 0.1706 
2 – 24 50.88 51.50 58.75 45.00 59.00 55.75 8.02 0.6890 0.4006 0.6568 
0 – 24 54.33 53.50 61.25 46.13 64.25 57.13 7.78 0.5831 0.2267 0.6611 
1
 Values are means ± pooled SEM (n=4). 
2
 Abbreviations: ARG, arginine; g, gram; h, hour; LPS, lipopolysaccharide. 
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Table 4. Performance at 2 h and 24 h post LPS injection in chicks fed either 1.1%, 1.3%, 
or 1.5% dietary ARG 1,2 
 1.1% ARG 1.3% ARG 1.5% ARG SEM P-value 
Gain, g/c*d      
 0 – 2 h -8.00 -14.00 -11.75 2.14 0.1901 
 0 – 24 h 0.25 -8.50 12.50 8.87 0.2926 
Feed conversion,  
g Feed intake/g BW 
gain      
 0 – 2 h -0.28 -0.08 -0.12 0.05 0.0570 
 0 – 24 h 0.30 -8.68 2.18 10.0 0.7224 
1
 Values are means ± pooled SEM (n=4).  
2
 Abbreviations: ARG, arginine; BW, body weight; c, chick; d, day; g, gram; LPS, 
lipopolysaccharide. 
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Table 5. Mean cell concentration of PBMC isolated from chicks fed 1.1%, 1.3%, or 1.5% dietary ARG at 2 h or 24 h post LPS 
injection 1,2 
  1.1% ARG 1.3% ARG 1.5% ARG  P-value 
PBMC (108/mL) Time, h  - LPS + LPS - LPS + LPS - LPS + LPS SEM ARG LPS ARG X LPS 
Viable             
 2 1.427 0.789 1.167 0.964 1.364 0.797 0.180 0.9719 <0.01 0.4476 
 24 1.131 0.948 1.242 0.932 1.035 0.944 0.202 0.8827 0.2317 0.8633 
Apoptotic            
 2 0.011 0.016 0.010 0.009 0.012 0.010 0.002 0.2431 0.6515 0.1828 
 24 0.007 0.011 0.011 0.011 0.007 0.012 0.003 0.7875 0.2583 0.6886 
Dead            
 2 0.022 0.037 0.027 0.026 0.028 0.023 0.007 0.8310 0.6525 0.3318 
 24 0.017 0.022 0.017 0.042 0.015 0.043 0.010 0.5199 <0.05 0.4615 
1
 Values are means ± pooled SEM (n=4).   
2
 Abbreviations: ARG, arginine; h, hour; LPS, lipopolysaccharide; PBMC, peripheral blood mononuclear cell. 
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Table 6. PBMC phenotyping of cells isolated from chicks fed 1.1%, 1.3%, or 1.5% dietary ARG at 2 h and 24 h post LPS injection 1,2 
   1.1% ARG 1.3% ARG 1.5% ARG  P-value 
 Time, h LPS - + - + - + SEM ARG LPS ARG X LPS 
%CD4+             
 2  11.71 3.92 12.89 7.29 8.64 6.16 1.33 0.2255 <0.01 0.1789 
 24  12.66 10.87 10.54 10.21 10.69 9.98 1.04 0.2763 0.2314 0.7940 
%CD8+             
 2  5.26 2.25 5.42 2.43 3.99 2.29 0.76 0.6804 <0.01 0.6453 
 24  4.04 5.71 3.92 3.19 4.33 2.81 0.79 0.2681 0.5561 0.1635 
CD4:CD8             
 2  2.52 1.95 2.40 3.20 2.32 2.79 0.33 0.2970 0.4340 0.1336 
 24  3.32 2.44 2.93 3.32 2.50 3.74 0.48 0.8638 0.5562 0.1122 
%B cells             
 2  4.07 1.83 5.52 1.66 2.48 2.75 1.11 0.8556 <0.05 0.1263 
 24  4.42 3.64 3.92 3.82 7.23 2.04 1.43 0.9756 0.0708 0.1402 
%Monocytes             
 2  42.87 3.07 43.72 15.38 36.71 3.87 7.84 0.4056 <0.01 0.6626 
 24  53.26 42.41 47.07 46.65 34.02 29.69 9.43 0.1816 0.4606 0.9060 
1
 Values represent means ± pooled SEM (n=4). 
2
 Abbreviations: ARG, arginine; h, hour; LPS, lipopolysaccharide; PBMC, peripheral blood mononuclear cell. 
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Table 7. Mean mRNA abundance of cytokines from spleens of chicks fed 1.1%, 1.3%, or 1.5% dietary at 2 and 24 h post LPS 
administration 1,2 
  1.1% ARG 1.3% ARG 1.5% ARG  P-value 
Gene Time, h  - LPS + LPS - LPS + LPS - LPS + LPS SEM ARG LPS ARG X LPS 
IL-1β            
 2 0.68 4.28 1.00 9.53 0.34 10.27 2.88 0.5302 <0.01 0.5262 
 24 0.96 1.71 0.92 1.20 1.06 1.72 0.51 0.7636 0.1676 0.8861 
IL-6            
 2 0.55 15.91 1.00 56.49 0.40 73.20 22.86 0.4445 <0.05 0.4517 
 24 1.04 1.24 0.94 0.53 0.96 1.16 0.57 0.7398 0.9905 0.8266 
IL-18            
 2 1.68 15.81 1.00 18.18 1.18 21.12 3.26 0.7450 <0.01 0.6770 
 24 1.29 3.24 2.56 4.07 2.09 2.70 0.74 0.3016 0.0317 0.6574 
IFN-γ            
 2 1.49 35.74 1.00 49.28 9.73 102.69 21.05 0.1895 <0.01 0.3670 
 24 0.69 2.02 0.94 2.06 1.80 1.43 0.63 0.9172 0.1957 0.3592 
TGF-β2            
 2 0.77 0.69 1.00 0.82 0.81 0.89 0.26 0.7702 0.7525 0.8846 
 24 0.89 1.75 0.87 0.68 1.53 1.01 0.53 0.5346 0.9036 0.4152 
TGF-β4            
 2 0.94 2.17 1.00 6.95 1.40 2.39 1.17 0.1480 <0.05 0.0848 
 24 1.36 1.05 1.08 1.25 1.40 0.71 0.34 0.9014 0.3263 0.4551 
1
 Values represent means ± pooled SEM (n=4).  For each gene, data are presented as the normalized fold-change in mRNA abundance 
relative to 1.30% ARG at 2 h post-injection from un-injected chicks. 
2
 Abbreviations: ARG, arginine; h, hour; IFN, interferon; IL, interleukin; LPS, lipopolysaccharide; TGF, transforming growth factor. 
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Figure 1. PBMC phenotyping of A) CD4+ T cells, B) CD8+ T cells, C) B cells, and D) 
monocytes isolated from broiler chicks fed 1.1%, 1.3%, or 1.5% dietary ARG at 2 h post 
LPS administration.  PBMC were isolated, enumerated, and phenotyped as described in 
sections 3.3 and 3.4.  Values represent means ± SEM (n=4).  Means not sharing a 
common superscript differ (P<0.05).  Abbreviations: ARG, arginine; LPS, 
lipopolysaccharide; PBMC, peripheral blood mononuclear cell. 
99 
 
CHAPTER 4 
Conclusion 
4.1. Summary 
In the present studies, broiler chicks served as an animal model not confounded 
by de novo ARG synthesis.  These studies suggest that the optimal level of dietary ARG 
supplementation for utilization by genes coordinating ARG uptake and release in 
leukocytes is higher than what is sufficient for growth and is both age and leukocyte 
dependent.  These studies also suggest that the level of dietary ARG supplementation to 
manipulate leukocyte phenotype in peripheral blood is also higher than what is sufficient 
for growth.  Additionally, ARG transporter mRNA abundance indicates that the immune 
system has redundant pathways for ARG acquisition and retention in both quiescent 
(PBMC) and proliferating (thymocytes) cells.  In PBMC, ARG importer (CAT-1) mRNA 
abundance on d7 posthatch was increased with 1.35% dietary ARG compared to 1.20% 
dietary ARG.  In thymocytes, ARG exporter (y+LAT-2) mRNA abundance was 
decreased with 1.35% dietary ARG compared to 1.20% dietary ARG.  When considering 
leukocyte phenotype, the percentage of B cells and monocytes in peripheral blood were 
higher from chicks fed 1.5% ARG than from those fed 1.1% and 1.3% ARG on d17 and 
d14 posthatch, respectively.  Also, the present studies have shown that dietary ARG can 
be utilized to manipulate the severity of the APR.  Adequate dietary ARG levels tended 
to alleviate negative feed conversion and increase the splenic mRNA abundance of the 
anti-inflammatory cytokine, TGF-β4. 
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4.2. Future Studies 
 Many additional studies should be performed to further explore the impact of 
dietary ARG supplementation on ARG utilization for immunity.  First, the functional 
response of PBMC to dietary ARG levels should be evaluated.  For instance, 
monocyte/macrophage phagocytosis and/or NO production in cells isolated from 
peripheral blood of chicks fed different dietary ARG levels will demonstrate if dietary 
ARG impacts their function and taken together with the changes in ARG transporter 
mRNA abundance in the present studies it will help further our knowledge concerning 
ARG utilization by leukocytes.   
Second, to compliment evaluation of ARG’s impact on NO production, 
experiments that examine the ARG metabolizing enzymes, iNOS and arginase, in 
leukocytes should be carried out to further understand how dietary ARG level impacts 
ARG utilization in immune cells.  The mRNA abundance or the protein abundance of 
these enzymes in PBMC and thymocytes could be determined by quantitative real-time 
PCR or Western blot, respectively.  However, to examine the respective proteins by 
western blot, antibodies for these enzymes in broiler chicks would need to be 
manufactured.  Alternatively, iNOS and arginase activities could be examined with 
commercially available kits. 
Third, to extend the thymocyte ARG transporter and proliferation data obtained in 
these studies, an additional experiment examining recent thymic emigrants in peripheral 
blood of chicks fed different dietary ARG levels could be performed.  This would 
indicate if ARG’s impact on developing cells from the thymus has implications for T cell 
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populations in peripheral blood and could be easily performed via flow cytometry by 
labeling peripheral blood T cells with a commercially available antibody for ChT1 which 
is present on recent thymic emigrants (1). 
Fourth, an experiment that would be quite interesting would be to attempt to 
determine dietary ARG’s impact on the T cell receptor (TCR) complex in aves in 
comparison to findings in mammalian T cells in which ARG impacts expression of the 
primary signal transduction element (CD3ζ chain) of the TCR complex (2).  This would 
provide information pertaining to ARG’s impact on T cell signaling and cell-mediated 
immunity. 
Finally, additional studies concerning dietary ARG’s impact on ARG utilization 
for immunity under periods of infection should be considered.  Dietary ARG’s impact on 
the severity of the APR should be considered in a much larger study that characterizes 
cytokine profiles in additional cells and tissues.    
 
4.3. Implications 
The present studies have indicated that dietary ARG levels for growth are not 
necessarily appropriate for ARG utilization by leukocytes.  This indicates that 
understanding nutrient supplementation for immunocompetence in addition to nutrient 
supplementation for growth has important implications for animal nutrition and dietary 
recommendations.  Additionally, since ARG is an immunomodulator as a substrate 
utilized by leukocytes, real-time adjustments of dietary ARG levels may eventually be 
used to manipulate an immune response in a particular situation. 
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